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High Resolution Hybrid Mass Spectrometry for the Determination of Marine
BiotoxinSf AzaspiracidSy and their Biotransformation Products.

ABSTRACT

Azaspiracids (AZAs), polyether marine toxins, are produced by marine microalgae and
accumulate in filter-feeding bivalve molluscs, such as mussels, clams, oysters and scallops,
while grazing on phytoplankton, from which they derive nutrition. Although being
discovered quite recently, AZAs have caused several human intoxication events and thus
became a problem for health authorities and shellfish industries. The rapid development of
highly sensitive liquid chromatography multiple tandem mass spectrometry (LC-MS/MS,
LC-MS") methods enabled the identification of numerous AZA analogues and added to the
control of shellfish contamination. Tandem mass spectrometry techniques, while being highly
selective and sensitive for determination of AZAs in complex shellfish matrices, are target
methods and therefore not suitable for detection of novel analogues, metabolites and
degradation products.
The aim of this research project was to develop a non-target mass spectrometric approach for
analysis of AZAs in shellfish and apply this to determination of AZAs in shellfish, to
elucidate their fragmentation pathways and to study their bioconversion processes in
shellfish. The overview of the marine toxins, the latest mass spectrometric, Orbitrap,
technology and the results of the exploration of the performance of the Orbitrap mass
spectrometer for analysis of the polyether biotoxins, azaspiracids, are described in seven
chapters of this Thesis:
1.

Firstly, five major human toxic syndromes caused by the consumption of shellfish

contaminated by algal toxins have been reviewed. The prevalence of harmful algal blooms
(HABs) is possibly a consequence of anthropogenic activities and global climate change.
Since the marine toxins have been proved to have negative implications for human health
increased toxin surveillance programmes and the development of reliable detection methods
are mandatory for limiting human exposure to shellfish toxins.

2.

The Orbitrap mass analyser is the most recent development in mass spctrometry

technology. Despite of the rather high price of the Orbitrap instruments, those beime very
popular and have been employed successfully in numerous applications for analys of both,
large and small molecules. The ability of Orbitrap technology to perform eually for
proteomics and for micropolutants is a result of multiple ion sources, mass malysers,
detectors and scan modes that can be implemented in the instrument.
3.

The most recently discovered, and possibly very potent, is the azaspiracic group of

polyether marine toxins. Although liquid chromatography coupled with mass spctrometry
(LC-MS) has become finally the official method for monitoring of azaspircids, the
suitability of the particular MS method should be evaluated as well. Previously-mployed
mass analysers allowed for sensitive and selective determination of azaspiracids i shellfish
tissue and phytoplankton. However, for the identification of unexpected ciaspiracid
analogues are non-target approaches better suited.
4.

fhe LTQ Orbitrap was exploited to develop and validate a full-scan fourierransform

(FT) MS method for analysis of azaspiracids in shellfish. A comparison of this on-target
approach with a target method, performed on linear ion trap mass analyser (,IT MS),
demonstrated suitability of the full-scan FTMS for analysis of azaspiracids in shellsh tissue.
A dependent scan, using higher collisioanally induced dissociation (HCD) U generate
product ion spectra from the ions observed in the full-scan, enhanced the identificaon of the
main metabolites of azaspiracid-1 in shellfish. Subsequently, this method enbled for
discovery of two major AZA analogues in scallops {Pecten maximus).
5.

Finally, the possibility of direct analysis of azaspiracids in shellfish extrcts using

nanoelectrospray providing automatic system, NanoMate, coupled to the Orbfap mass
analyser was explored. This LC free method allowed for development of a rapid;creening
method for the determination of AZAs in crude shellfish extracts, which havenot been
subjected to extensive clean-up procedures, thus preventing unpredictable losses c’ analytes
differing in physicochemical properties as well as those at trace concentration leveF
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CHAPTER 1

Phycotoxins
(Review)

1.1 Shellfish toxicity: human health implications of marine alga! toxins
Shellfish are a rich source of protein, essential minerals and vitamins A and D and they
feed mainly on marine microalgae. The importance of algae in the food chain arises from
the fact, that they are the only organisms that can readily make long-chain polyunsaturated
fatty acids (PUFAs) and the potential beneficial role of shellfish and finfish in the human
diet has been attributed to the presence of oils that are rich in PUFAs. [1] Bivalve molluscs
filter large volumes of water when grazing on microalgae, and can concentrate both
bacterial pathogens and phycotoxins. [2] A range of human illnesses associated with
shellfish consumption have been identified as being due to toxins that are produced by
marine microalgae. When algae populations increase rapidly to form dense concentrations
of cells, they may form visible blooms, the so-called ‘red tides’ (Figure 1.1), but blooms
are not always visible as they may not be coloured and they can proliferate well below the
surface. The term ‘harmful algal bloom’ (FIAB) is preferred and these events can have
negative environmental impacts, including oxygen depletion of water column and damage
to the gills of fish. Moreover, toxin-producing algae can cause mass mortalities of fish,
birds, marine mammals and human illness via consumption of seafood. It is estimated that
only 60-80 species of about 4000 known phytoplankton are potentially toxin-producing
and capable of producing HABs. [3]
The main vectors of algal toxins to humans are filter-feeding bivalve molluscs and
herbivorous fmfish that ingest toxic algae (Figure 1.2). The bivalve molluscs that are
mainly affected with algal toxins include mussels, clams, scallops and oysters. Although
crustaceans can also be contaminated with toxins, the extent of toxicity is generally low
and the incidences of human intoxications due to crustacean consumption are rare.

Figure 1.1. Algal bloom (red tide) in the Atlantic ocean by The Cliffs of Moher, Co. Clare, Ireland.

Other significant environmental impacts of HABs include major fish kills and large
mortalities to birds and marine mammals. [4; 5] One of the most dramatic events involving
sea mammals was the extensive mass mortalities to sea lion in California due to domoic
acid (DA) intoxication where the main vector was anchovy. [6] Figure 1.2 summarises the
interrelationships and potential vectors for toxins arising from HABs, but the toxic impact
to humans is predominantly from shellfish consumption. Bivalve shellfish graze on algae
and concentrate toxins, if present, very effectively.
Historically, there have been sporadic reports of shellfish poisoning; one fatal incident that
occurred in British Columbia in 1793 was reported by Captain Vancouver and the earliest
scientific reference to shellfish poisoning appeared in 1851. [7]

Marine Mammals

Crustaceans
Birds

Figure 1.2. I'he toxin cycle: diagram illustrating the interrelationships between harmful algae and
shellfish, finfish, birds and mammals.

Prohibitions regarding the consumption of shellfish are found in several cultures and,
together with religious believes, this has limited the role of shellfish as a potential food
source. Such prohibitions are found in the Old Testament:

These ye shall eat of all that are in waters: all that have fins and scales shall ye eat: And
whatsoever hath not fins and scales ye may not eat; it is unclean unto you. (Deuteronomy
14: 9-10; King James Version)

In this chapter, five major human toxic syndromes caused mainly by the consumption of
bivalve molluscs contaminated by algal toxins are discussed.

1.2 Shellfish toxic syndromes

1.2.1 Paralytic shellfish poisoning (PSP)
Mild symptoms include a tingling sensation or numbness around the lips which gradually
spreads to the face and neck, accompanied by a prickly sensation in fingertips and toes.
Greater intoxications induce headache, nausea, vomiting and diarrhoea with increasing
muscular paralysis and pronounced respiratory difficulty. In the absence of artificial
respiration there is a high risk of death as a consequence of acute PSP intoxication. [4] The
onset of symptoms of PSP in humans is dose dependent and can occur rapidly (within 30
min) after the consumption of shellfish. PSP toxins are collectively called saxitoxins
(STXs) and at least 21 analogues of these cyclic guanidines are known in shellfish, with
saxitoxin (Figure 1.3) being the most common toxin. STXs exert their effect by a direct
binding on the voltage-dependent sodium channel blocking the influx of sodium and the
generation of action potentials in nerve and muscle cells, leading to paralysis. [8] I'he
primary site of action of STXs in humans is peripheral nervous system. The lethal dose in
humans is 1-4 mg STX, or equivalent STXs, and since levels up to 100 pg STX
equivalents/g shellfish have been reported, consumption of only a few contaminated
shellfish have proved fatal in these rare cases. However, hospitalisation of affected
individuals is critical to deal with respiratory paralysis and STXs clear from the blood
within 24 h leaving no organ damage or long-term effects. [9] Saxitoxin has reached
notoriety by being included, along with ricin, in the Schedule 1 list of the Chemical
Weapons Convention. Detection and control of PSP toxins in shellfish is less problematic
than the control of lipophilic toxins. PSP toxins are efficiently extracted from shellfish
tissues using a strong acid and a mouse bioassay (MBA) has been validated as an official
method by AOAC International. [10]

Figure 1.3. Structure of saxitoxin.

Dinotlagellates that produce STXs belong to three genera; Alexandrium, Gymnodinium and
Pyrodinium and HABs involving blooms of these dinotlagellates occur in both Northern
and Southern Hemispheres. [5] It has been estimated that there are 2000 human
intoxications per year and PSP outbreaks are seasonal. [11; 12J Although there is anecdotal
evidence of human intoxications associated with shellfish for centuries, a PSP outbreak
that occurred in northern California in 1927 led to a major investigation of this
phenomenon. Poisoning of 102 individuals from mussel consumption caused six deaths.
[13] PSP outbreaks have occurred on both the eastern and western coastlines on North
America, with Alaska being particularly badly affected and toxic events have been
reported for more than 130 years. [14; 15] Large marine mammals have also been affected
by PSP and 14 humpback whales died in Cape Cod Bay in 1987 from exposure to STXs
where mackerel was suspected to be the main vector. [16] Although STXs are detected in
the coastal waters and shellfish in many European countries, human intoxications are rare.
In the 1970s, there were several PSP intoxications involving 80-120 individuals, caused by
mussels produced in Spain, Portugal and the UK [17; 18; 19] but implementation of good
regulatory control has effectively eliminated further major outbreaks. There have been
repeated PSP outbreaks in Chile and Argentina during the past 40 years, with 21 PSP
deaths reported in Chile since 1991 [20], and these investigations included one of the rare

identifications of toxins in the body fluids of victims. [21] In the Philippines, there have
been an estimated 2000 cases of PSP between 1983 and 1998, with 115 deaths. [22]
Blooms of Pyrodinium spp. were the main cause of these intoxications and these blooms
have spread throughout the tropical Pacific region. Climate change has been implicated
with an apparent correlation between these HABs and the occurrence of El Nino Southern
Oscillation events. [23] PSP events in geographically remote locations cause higher death
rates due to the lack of hospital facilities with respiratory support equipment.

1.2.2 Amnesic shellfish poisoning (ASP)
The poisoning is characterised by clinical symptoms and signs including the
gastrointestinal tract, the central nervous system and the cardiovascular system. The
gastrointestinal symptoms included nausea, vomiting, abdominal cramps and diarrhea
within 24 h and neurological symptoms such as headache, confusion, disorientation,
unstable blood pressure, cardiac arrhythmias, coma, seizures, memory loss and death were
observed within 48-72 h. The memory impairment that was observed only in individuals
above the age of 50 years, resulted in naming this symptom. Amnesic Shellfish Poisoning
(ASP). [24; 25; 26; 27; 28]
Domoic acid (DA) (Figure 1.4) and analogues were identified as the causative agent,
produced by different species of marine diatoms Pseudo-nitzschia [29] and the red algae
Chondria armata [30]. The most common vector of human intoxication is the blue mussel
{Mytilus edulis) [31; 32], however DA was also found in other shellfish and
crustaceans[31; 33; 34; 35; 36].

COOH
HOO(

COOH
H

Figure 1.4. Structure of domoic acid.

Domoic acid induces excitotoxicity by the activation of glutamate receptors in the central
nervous system. This leads to the opening of Na^ channels and to Na^ ion influx, resulting
in depolarization and Ca^ ion influx, causing toxic effect and cell death. [4; 37]
Domoic acid is a water soluble tricarboxylic amino acid. Among the analytical techniques,
used for the detection of DA in seawater, plankton and shellfish, are a number of biological
and chemical assays, however liquid chromatography with ultra-violet detection is most
widely used, with a regulatory limit of 20 pg DA/g shellfish tissue. [38]
First ASP outbreak, in the 1987, caused severe human illness and mortalities in Canada.
The intoxication was caused by blue mussel {Mytilus edulis) contaminated by the DA
group of toxins. [26] The epidemiology data reported over 100 victims, of which 19 of the
most severe cases were hospitalised for 4 - 101 days. A total of 12 patients were admitted
to intensive care, and three died in hospital between 12 and 18 days after admission.
Another patient died after three months. It has been established, that the severity of the
illness and memory loss increased with the age of the patients. [27; 39; 40; 41]
Specific control measures implemented in Canada and many other countries around the
world have been successful in preventing other episodes of ASP. [42; 43] This however
couldn’t prevent exposure of wild animals, including sea lions, whales, sea otters and sea
birds to ASP toxins. [6; 44; 45; 46; 47; 48] Perhaps the most dramatic event took place in
California during May and June 1998, involving 70 sea lions {Zalophus californianus)
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displaying neurological dysfunction, resulting in the deaths of 47 animals. DA was
detected in the sea lion body fluids and also in the northern anchovy {Engraulis mordax),
collected in the affected area. [6] Another report of an outbreak of DA poisoning was in
Monterey Bay, California, in 1991 where 95 cormorants {Phalacrorax penicillatus) and 43
brown pelicans {Pelecanus occidentalis) died after eating the anchovies that were
contaminated with high levels of DA. [49] Following the implementation of monitoring
programmes in Europe, DA has been detected in shellfish from Galicia, Spain [50], Ireland
[51], Portugal [52], Scotland [53] and France [54]. New Zealand, Australia, Mexico and
South Korea have also been affected by ASP group of toxins but major human
intoxications have not been reported. [55]

1.2.3 Neurotoxic shellfish poisoning (NSP)
Symptoms of NSP include neurological and gastrointestinal disturbance. Most individuals
report multiple symptoms. The characteristic sign of both gastrointestinal and neurological
symptoms occurs at approximately the same time, within a few minutes, with the
neurological symptoms lasting longer, up to 18 h, than the gastrointestinal discomfort.
Mild to moderate nausea, vomiting and diarrhea are often reported, followed by numbness
and tingling in the lips, mouth and face, as well as numbness and tingling in the
extremities. Slurred speech, disorientation, headache, pupil dilation, and overall fatigue are
also commonly reported, together with the reversal of hot and cold sensation, ataxia,
overall loss of coordination, and partial limb paralysis. Despite dramatic presentation,
victims reportedly recover within 2-3 days and there are no long-term or chronic effects of
NSP documented in the literature. [56; 57; 58]
Brevetoxins (Figure 1.5), polyether toxins responsible for NSP, are primarily produced by
the dinoflagellate, Karenia brevis. [56]
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Blooms of K. brevis, called Florida red tide, occur frequently along the Gulf of Mexico.
The exposure to the aerosols containing brevetoxins, released from fragile K. brevis
dinoflagellate, cause irritation of the eyes and nasal membranes, followed by respiratory
problems. [59]
The neurotoxicity of brevetoxins is caused by their ability to bind with high affinity to
receptor on the voltage-gated sodium channel and induce a channel mediated Na^ ion
influx. Neuro-excitation, paralysis and fatigue of excitatory cells, results from the nerve
membrane depolarization and spontaneous firing. [60]
Brevetoxins accumulate in bivalve molluscs and also affect finfish, aquatic mammals and
birds. In 2002, this group of toxins caused the deaths of 34 Florida manatees {Trichechus
manatus latirostris) and in 2004 the deaths of 107 bottlenose dolphins {Tursiops truncatus)
also occurred. High levels of brevetoxin were detected in the fluids and the tissues of dead
animals. [61; 62]
Green mussel, cockles and oysters were implicated in the largest documented outbreak of
NSP that occurred in New Zealand in 1992-1993, with over 180 human cases reported over
a period of several weeks. [63] The largest and best documented outbreak in the United
States occurred in North Carolina. In October 1987 a K. brevis bloom appeared in the Gulf
Stream off eastern Florida and was transported up the eastern seaboard where 48 human
cases were identified in the ensuing weeks. [57]

There have been three distinct methodologies for the assessment of brevetoxins in
environmental and biological samples. These include the mouse bioassay (MBA) test
which usually takes up to three days to complete, making it very slow in reporting. The
enzyme-linked immunosorbent assay (ELISA) for brevetoxin is an antibody based assay,
that allows for the detection and quantification of brevetoxins at very low levels. The third
traditional method for detection, identification and quantification of brevetoxins takes
advantage of recent advancements in high performance liquid chromatography (HPLC)
with mass spectrophotometry (MS) detectors. [62; 64]
As a result of the implementation of monitoring programmes for presence of K. brevis and
other brevetoxin-producing organisms in the US, only a few NSP cases are reported
annually. However, cases usually associated with recreationally-harvested shellfish
collected during or post red tide blooms do occur and represent a threat to human health.
[62]

1.2.4 Diarrhetic shellfish poisoning (DSP)

DSP is a gastrointestinal illness and the main symptoms are diarrhea followed by nausea,
vomiting and abdominal cramps. DSP can occur within 30 min to a few hours after
ingestion of contaminated shellfish and complete recovery occurs within three days. Since
clinical tests are rarely used for DSP toxins, this condition is often confused with bacterial
enterotoxin poisoning. DSP is caused by the ingestion of contaminated filter-feeding
bivalve molluscs, especially mussels and scallops, where the lipophilic toxins are
accumulated mainly in the digestive glands (hepatopancreas). [65]
DSP toxins were originally divided into three different structural classes: {a) okadaic acid
(OA) (Figure 1.6.a) and its analogues, dinophysistoxins (DTXs), {h) pectenotoxins (PTXs)
(Figure 1.6.b) and (c) yessotoxins (YTXs) (Figure 1.6.c). [66] However, YTXs have now
been excluded from the DSP classification because they are not orally toxic and do not
10

induce diarrhea. [67] PTXs and YTXs are toxic to mice upon intraperitoneal injection,
which was the official, but primitive, DSP testing procedure. However, no ease of human
poisoning due to these toxins has been reported. The strange scenario when using the
official MBA is that the least toxic substances, YTXs, elicit the highest toxic response. [4]
Not only are these lethal bioassays prohibited in several countries, including Germany, The
Netherlands and Sweden, alternative methods for toxin determination could only be
implemented in the EU when they have been validated against the MBA which itself has
never been validated. [68] A pronouncement from the European Food Safety Authority
belatedly acknowledged the unacceptable current regulatory situation and stated:

The mouse hioassay (MBA) is the official reference method for lipophilic biotoxins. The
Panel on Contaminants in the Food Chain (CONTAM Panel) noted that this hioassay has
shortcoming's and is not considered an appropriate tool for control purposes because of
the high variability in results, the insufficient detection capability and the limited
specificity.

In November 2010, the EU Commission officially adopted liquid chromatography coupled
with mass spectrometry as a reference method for lipophilic biotoxins.

11

Figure 1.6.a. Structure ofokadaic acid.

Figure 1.6.b. Structure of pectenotoxin-2.

Figure 1.6.c. Structure of yessotoxin.

12

The mechanism of action of the OA group toxins is via inhibition of serine-threonine
protein phosphatase 2A (PP2A) which plays important roles in many regulatory processes
in cells. OA probably causes diarrhea by stimulating phosphorylation of proteins that
control sodium secretion in intestinal cells. [69] Although protein phosphatase assays are
very sensitive and can be readily applied for detecting OA and analogues in shellfish, LCMS methods are more widely used. [70; 71] Despite the fact, that DSP is not fatal, this type
of poisoning deserves attention, because in addition to the severe acute effects, the chronic
effects may be important as OA and DTXl have been shown to be potent tumour
promoters. [72; 73] A major risk factor for colorectal cancer from shellfish consumption
has been proposed due to the presence of DSP toxins. [74]
The first confirmed outbreak of DSP occurred in Japan in the late 1970s with 164 cases of
shellfish poisoning. [75] There were 34 outbreaks of DSP in Japan between 1976 and
1984, affecting more than 1000 people. [76] DSP outbreaks have involved large population
numbers and have affected the greatest number of individuals compared to the other
shellfish toxic syndromes. In Europe, DSP outbreaks involving several thousand
individuals have been reported since 1978 in France [77; 78], Norway and Denmark [79],
Spain [80; 81] and mussels exported from Ireland have caused DSP outbreaks throughout
Europe [82]. Despite DSP monitoring, mussels from Denmark caused DSP intoxications to
more than 1000 individuals in Belgium [83]. DSP is now recognised as a worldwide
problem and also affects Canada, Chile, Argentina and New Zealand. DSP toxins are
produced by the dinoflagellates, Dinophysis spp. and Prorocentrum spp. and their toxin
profiles can vary within a single species. [84; 85; 86] In Europe, OA and its isomer, DTX2,
are the predominant DSP toxins and they co-occur in shellfish from Ireland [87], Portugal
and Spain [88]. DTXl, the methyl analogue of OA, is the predominant DSP toxin in Japan
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[85; 89] and can be found only in one region of Norway, in Sognefjord [90]. The
regulatory level for these toxins in Europe is currently 0.16 pg/g.

1.2.5 Azaspiracid poisoning (AZP)

AZP is the main topic of this Thesis and is discussed in detail in the Chapter 3.
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1.3 Global increase in harmful algal blooms (HABs)
There has been an apparent global increase in the occurrence of algal toxins in shellfish,
with several new toxin classes identified in recent years. However, the reasons behind the
apparent expansion in HABs and shellfish toxicity remain unclear with a number of factors
being implicated including, climate change, anthropogenic activities, changes in shellfish
cultivation, eutrophication, increased global marine traffic, improved toxin detection and
better food control and toxin monitoring programmes. [12; 91; 92; 93] Projected increases
in ocean temperatures are predicted to change global circulation that may lead to an
increase of HABs. Moreover, the increased concentrations of greenhouse gases are
expected to reduce pH, increase surface-vv^ater temperatures and affect vertical mixing and
upwelling. [94] Phytoplankton growth is dependent on the availability of nitrogen.
Atmospheric deposition of nitrogen, from agricultural and urban sources, can lead to
increased algal blooms. [3; 95] Most marine HABs are comprised of dinoflagellates. The
mobility characteristics of dinoflagellates allow them to swim under stratified layers of the
water column to access nutrients in deeper layers. This may give dinoflagellates a
competitive edge over other phytoplankton that cannot swim. [94] The potential
consequences of these changes for HABs have received relatively little attention and are
not well understood. Several studies have emphasised the relevance of coastal
eutrophication to increased incidence of HABs and this is especially relevant to shellfish
production and intoxication. [92] Increased coastal aquaculture activities can lead to local
nutrient enrichment and eutrophication which not only increases the growth of toxic algae
but also acts as the main vector for increased exposure of humans to toxins. A remarkable
example of the positive effects of reducing nutrient loading was in Hong Kong harbour
where the frequency of algal blooms declined after several years of nutrient reduction. [96]
However, many algal blooms are not due to national anthropogenic activities and toxic
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algae can be transported from remote oceanic regions to affect coastal regions which have
normally pristine waters. Thus, in Europe, the major shellfish toxicity from HABs occurs
along the western Atlantic coastline, affecting Scotland, Norway, Ireland, France, Spain
and Portugal, but the Mediterranean region which has a high nutrient loading, has a low
incidence of such problems. It is therefore prudent to caution against a rush to judgement
until there has been an extensive database of algal population flux over an extended period
of years.
The emergence of non-indigenous toxic algal species in various geographical locations has
been linked to an increase in global marine traffic. In particular, the release of ballast
waters has been shown to be responsible for invasions of exotic species, including algae,
bacteria and zooplankton. Algal cysts in ballast waters have been identified as the cause of
new PSP events in regions of Australia that were previously unaffected and led to new
ballast water guidelines to limit exposure to exotic species. [5; 97] Recent evidence of an
increased global expansion of HABs includes the first reports of palytoxin and
tedrodotoxin in European waters and the discovery of azaspiracids in Japan. [98] An
outbreak of respiratory illness in people exposed to marine aerosols occurred in Genoa,
Italy, in 2005 and a palytoxin analogue was identified as the probable causative agent. [99]
Ostreopsis spp. are widely distributed in tropical and subtropical areas, but recently these
dinoflagellates have also started to appear in the Mediterranean where they produce
palytoxins. [100; 101] Tetrodotoxin is a well known paralytic toxin that is found in
pufferfish and causes fatalities in Japan almost annually. [102] Once again, a toxin that is
usually found in tropical and sub-tropical waters appeared in a trumpet shellfish (Charonia
sauliae), harvested from the Atlantic coastline of Portugal. An individual was hospitalised
and suffered general paralysis, including the respiratory muscles, a few minutes alfer the
consumption of several grams of this shellfish. The investigation of the extent and

16

implications of these new toxic problems in Europe is currently the subject of a
collaborative EU project. (ATLANTOX) [103]
Parts of this chapter are published as a review. [104]
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CHAPTER 2

Hybrid Linear Ion-trap Orbitrap Mass
Spectrometry: An overview

2.1 Introduction
Mass spectrometry is the most powerful among instrumental analytical methods. Different
physical principles have been implemented for analysis of mass/charge ratios including the
measurements of momentum in magnetic sector and kinetic energy in electrostatic sector
instruments, path stability in linear quadrupoles, orbital frequency in ion cyclotron
resonance mass spectrometers as well as in quadrupole ion-traps, and velocity is measured
in time-of-flight instruments. Each approach has great strengths but there are also inherent
weaknesses. [105] Ion trapping techniques became important tools in mass spectrometry,
but most ion-trap mass analysers do not deliver sufficient mass accuracy and have
relatively low space charge capacity. Orbitrap mass analyser overcomes these problems by
dynamic ion trapping in a constant electrostatic field and delivers
a) ultra high mass resolution (up to 150 000 FWHM),
b) increased space charge capacity at higher masses,
c) high mass accuracy,
d) high dynamic range.
Moreover, those excellent characteristics are achievable without compromising sensitivity
[106], which makes the LTQ Orbitrap the most desired tool for wide range of applications
from trace-level component analysis to proteomics and drug metabolomics. Recombination
of an Orbitrap detector with another mass analyser, a linear ion-trap (LIT), greatly
enhances elucidation of analyte structure due to multiple levels of the fragmentation (MS")
provided by the LIT and high mass accuracy measurements acquired on the Orbitrap mass
analyser. This combination also enables coupling with continuous ionisation sources
including atmospheric pressure chemical ionisation source (APCl), electrospray (ESI) and
matrix-assisted laser desorption ionisation (MALDI).[107]
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2.2 LTQ Orbitrap mass spectrometer
The Orbitrap mass analyser was first described in 200(by Alexander Makarov [106], and
subsequently commercialised by Thermo Scientific i part of a tandem-in-space mass
spectrometer using linear quadrupole ion-trap mass an.yser and introduced in 2005 at the
ASMS meeting in Texas, USA, The LTQ Orbitrap W has become a mainstream mass
spectrometry technique used for many applications in vious areas. [107]
The Orbitrap, fourier transfonn (FT), mass analyser wlch employs orbital ion trapping in
an electrostatic field, consists of an outer barrel-likedectrode and central spindle-like
electrode along the axis (Figure 2.1). The mass/chargem/z) ratio of ions is derived from
the frequency of harmonic oscillations along the axijof the field, which is determined
using image current detection and fast FT algorithms. [16]

m/z

Figure 2.1. Cutaway of the Orbitrap mass analyzer. Ions annjected between (a) central electrode
and (b) outer electrode. Frequency of axial oscillations depds on the m/z values of rotating ion
packages and induces an image current on (c) split outer elecodes. [ 108]
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Ions produced by the ion source are transferred through several stages of differential
pumping from the atmospheric pressure ion source into the linear ion-trap analyser, an
important link between continuous ion spray source and the Orbitrap operating in pulsed
mode (Figure 2.2). The population of ions entering the linear ion-trap and Orbitrap mass
analysers is controlled automatically via Automatic Gain Control (AGC) implemented in
Orbitrap technology. Ion gating is performed by measuring of the total charge using a
prescan to determine precisely the ion injection time. [109] AGC provides extended
dynamic range and insures optimal performance of both mass analysers. The linear iontrap analyser is also an independent MS detector and can store, isolate and fragment ions,
which can be scanned out and detected by an independent set of detectors. To obtain high
accuracy mass measurements, the ions are axially ejected into a gas-filled RF only curved
linear trap (C-trap), where ions lose a portion of their kinetic energy and are cooled down
to the axis of the C-trap by collisions with nitrogen gas.

Ion source

Ion optics

LIT
CID/PQD/ETD

Ion optics

C-trap

HCDcell

Orbitrap

Figure 2.2. Schematic of the LTQ Orbitrap XL a hybrid MS offering
Multiple Scan Modes
Multiple Collision Cells
Multiple Dissociation Methods
Multiple Mass Analyzers
Multiple Detectors
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After trapping the RF is ramped down electrodynamically squeezing the ions into a smaller
packet in the centre of the C-trap and the DC potential is ramped up, creating a field across
the trap that is orthogonal to the curved axis, to accelerate the ion packet out of the C-trap
into the Orbitrap mass analyser (Figure 2.3).
As the ions enter the Orbitrap mass analyser, the voltage on the central electrode increases
and ions, squeezed by its electrostatic field, are forced to oscillate along the central
electrode (left-right). Ions of each m/z ratio arrive at the entrance of the Orbitrap as short
packets due to the fast pulsing of ions from the C-trap. Lighter ions enter Orbitrap earlier
and oscillate closer to the central electrode than heavier ions. The ions entered the Orbitrap
slightly off axis and are kept oscillating by changing voltages. Electrostatic attraction is
compensated by centrifugal force arising from the initial tangential velocity of ions
entering the Orbitrap and ions are kept axially by potential barriers created by endelectrodes. Ion trajectories become stable spirals when voltage of the central electrode
stops increasing. Ion packets of the same m/z value spread over the angular coordinate and
form a rotating ring.

Figure 2.3. Schematic i^e^ti^ of ions from C-trap to Orbitrap. [110]
V>

,

>
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Stable trajectories combine rotation around the central electrode with oscillations along the
axis but only the frequency of axial oscillations (cOz) of each ring, which does not depend
on energy and angle, can be used for mass analysis. The image current, proportional to the
number of ions in the ring harmonically oscillating along the axis with a frequency
characteristic of their m/z values, is recorded on the outer split electrodes. Complex signal
generated by multiple ions is amplified and transformed into a frequency/intensity
spectrum by fast fourier transformation which is finally converted into a mass spectrum.
All ions are detected simultaneously in FT MS by measuring the image current that the
ions induce on the detection electrodes (Figure 2.4) [110].

Mixture of
Frequency-Amplitu
de Pairs
Fourier
transform

Frequency

if

Figure 2.4. Cutaway of the Orbitrap mass analyzer [110]
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2.2.1 HCD collision cell
The collision cell providing higher energy collisionalHnduced dissociation (HCD) is a
multipole collision cell that can be linked to the Orltrap mass analyser via a C-trap
(Figure 2.5). To obtain HCD MS/MS data, ions are pssed through the C-trap into the
collision cell. The offset between the C-trap and HCD cll accelerate selected ions into the
gas-filled collision cell. The Ifagment ions generated uing HCD are transferred through
the C-trap to the Orbitrap for high mass resolution and ligh accuracy mass measurement.
The product ion spectra generated by HCD is comparole to CID mass spectra acquired
using a triple stage quadrupole MS. However not only igh resolution and mass accuracy
MS/MS spectra are recorded in the Orbitrap, but a full nass range acquisition of product
ions, including low mass ions, is enabled by HCD. [111] 112]

N2 line

H-ESI

Figure 2.5. Scematic coupling HCD collision cell into the Oritrap via C-trap.
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2.2.2 Pulsed Q Collision Induced Dissociation (PQD) on LTQ MS
In addition to CID for precursor ion activation and dissociation in linear ion-trap mass
spectrometer, a new dissociation technique. Pulsed Q Collision Induced Dissociation
(PQD), has been developed and implemented exclusively for linear ion-traps employed in
the Orbitrap technology. PQD is a three-step dissociation process involving the ion
activation at high Q values (high energies) and collecting product ions at low Q values,
producing information-rich spectra containing low m/z fragments that can enhance the
structural elucidation of compounds. Therefore, the PQD produced spectra are comparable
to the BCD spectra in the fragmentation efficiency and generation of the low m/z product
ions. However, since the fragmented ions are not analysed in the Orbitrap mass analyzer,
they are lacking high resolution and high mass accuracy, which makes the BCD more
reliable for the compound structure identification.
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2.3 Modifications of Orbitrap technology
The instrument described in this chapter is the LTQ Orbitrap XL, a hybrid FTMS (Fourier
Transform Mass Spectrometer) and from the previous version, LTQ Orbitrap Discovery,
differs in addition of a new HCD collision cell and in improved mass resolution (up to 150
000 FWHM). The LTQ Orbitrap XL equipped with an electron transfer dissociation (ETD)
source

becomes LTQ Orbitrap XL

ETD,

designed

for protein

identification,

characterisation and quantitation. To perform ETD in linear ion-trap, the ETD anion
reagent ions are transferred from the ETD source through the HCD collision cell and Ctrap into the linear ion-trap where they are isolated and reacted with the precursor peptides
ions. Generated product ions can be measured in either the ion trap or Orbitrap mass
analyzers.
Addition of a matrix-assisted laser desorption ionisation (MALDl) source to the LTQ
Orbitrap XL give rise to the MALDl LTQ Orbitrap, ideally suited for proteomics and
metabolism applications. The ionisation is triggered by a laser beam (normally a nitrogen
laser) and matrix is used to prevent the destruction of the biomolecule by direct laser beam
and to facilitate vaporisation and ionisation.
The LTQ Orbitrap Velos, a hybrid dual-pressure linear ion-trap Orbitrap MS, combines the
Orbitrap mass analyzer equipped with HCD cell and the new LTQ Velos, a fast and more
sensitive ion trap mass spectrometer. The sensitivity is increased through enhanced ion
transmission from the ion source to the ion trap mass analyser using an S-lens, stacked-ring
ion guide, on the Velos linear ion-trap. Improved cycle time results from the dual-pressure
design of the Velos linear ion-trap, that combines high-pressure cell for improved isolation
and fragmentation efficiency and a low-pressure cell improving scan speed, resolving
power and mass accuracy.
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The Exactive Orbitrap LC-MS is a non-hybrid benchtop full scan MS system designed for
high-throughput and high-performance screening, compound identification, and for
qualitative and quantitative analysis, fully compatible with ultra-HPLC. Although the LTQ
MS is missing in this design, the optional HCD collision cell adds more functionality to the
bench-top system by providing ‘All Ion Fragmentation’.
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2.4 Applications of Orbitrap technology for small molecule analysis
Although the Orbitrap mass analysers are the most recently developed ion trapping devices
in the field of mass spectrometry, their success is phenomenal and considerable amount of
applications employing Orbitrap MS has encouraged further development in this
breakthrough technology. The diversity of Orbitrap mass spectrometers, enabling the use
of multiple scan modes, collision cells, dissociation techniques, mass analysers and
detectors, implemented in one instrument, supports a wide range of applications. Different
designs of liquid chromatography tandem mass spectrometry (LC-MS/MS) methods are
well established for analysis of trace levels of contaminants. However, an inherent
limitation of the use of targeted LC-MS/MS approaches is their inability to detect other or
novel residues for which no ion transitions are preselected. Therefore, there is a strong
trend in implementing non-target fiill-scan MS screening methods providing high
resolution and high mass accuracy for known as well as newly emerging compounds and
their transformation products.

2.4.1 Environmental analysis
Demanding regulatory limits for micropollutants such as pesticides, pharmaceuticals,
industrial chemicals and their transformation products present in the environment have
resulted in the development of more reliable and sensitive methods employing high
resolution and high mass accuracy instruments. [113]
Full-scan MS, developed on the LTQ Orbitrap, has proved to be a powerful technique for
quantification of low molecular weight compounds at the picogram level in complex
matrixes. A method developed for the determination of nine A^-nitrosamines in wastewater
involved, CID MS/MS data obtained from the LIT, together with HCD MS/MS scans
acquired in C-trap were used for fragmentation studies. A mass resolving power of 25,000
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- 40,000 FWHM ensured sufficient selectivity for distinguishing all molecular and product
ions from interfering background ions. [114]
Two approaches, performed on an LTQ Orbitrap, were used for screening pharmaceuticals,
benzotriazoles, illicit drugs and metabolites in effluent, surface, ground and drinking-water
by Hogenboom et al Accurate mass screening was employed for the determination of
known contaminants. Full-scan screening of water samples followed by multiple tandem
MS data dependent scans in LIT enabled the identification of unknown micropollutants.
[115]
LC-ESI-MS using a linear ion trap Orbitrap hybrid instrument at a resolution setting of
30,000 FWHM in the full-scan acquisition mode was developed for the determination of
trace levels of six polar 1 H-benzotriazoles and four benzothiazoles in drinking and surface
water. CID MS/MS spectra of the compounds of interest were generated for confirmation
of their identity. Optimisation of the method involving extractions of these residuals from
water, using solid phase extraction (SPE), allowed their quantitation down to detection
limits of 0.01 pg/L. [116]

2.4.2 Analysis of residues in the food and feed
Analysis of contaminants in foodstuffs is more challenging due to the complex matrix,
from which analytes need to be extracted. More selective and sensitive methods for their
determination are also needed in order to meet strict regulatory limits for contaminants in
food and feed.
LC coupled with time-of-tlight (TOF), Fourier transform ion cyclotron resonance (FTICR)
or Fourier transform Orbitrap (FT Orbitrap) MS was used for screening and confirmation
of targeted analytes and for the identification of unknowns using the anabolic steroid
stanozolol and the designer (3-agonist “Clenbuterol-R” as model substances. Importance of
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sufficient mass resolution for assignment of accurate masses in both MS screening and
MS/MS confirmation of stanozolol in urine was demonstrated. [117]
A method for the determination of azaspiracids in shellfish employed both mass analysers
implemented in LTQ Orbitrap system. Full-scan FTMS was compared to CID MS/MS
acquired on linear ion-trap for quantitation of marine toxins azaspiracids in shellfish. In
this study HCD MS/MS dependent scan complemented fiill-scan data by structural
information for targeted analytes. A full-scan method, using a 100,000 FWHM resolution
setting with ± 2 mDa tolerance window, proved to be selective and sensitive for the
determination of azaspiracids in complex shellfish matrix and validation data were
comparable to those obtained by tandem mass analysis on a LIT MS. [118] A highthroughput method based on a simple sample preparation and ultra-high performance
liquid chromatography (U-HPLC), coupled through APCI source with full spectral orbital
trapping MS detection, was developed and validated for the analysis of 32 mycotoxins in
beer. [119] Acquiring high mass accurate data (< 2 mDa) in MS, MS and MS modes
allowed identification of 38 polyphenols in tomato samples, three of which were not
previously reported. [120] Multistage CID experiments (MS") in combination with HCD
data acquisition performed on the [M + H]" precursor ions, aided the elucidation of the
mass fragmentation pathways of potato glycoalkaloids, alpha-solanine and alphachaconine, and the aglycons, demissidine and solasodine prior to analysis using the
Orbitrap Fourier transform (FT) mass spectrometer. [121]
Kellmann et al. investigated the extent of resolution that is required for the analysis of
mixture of 151 pesticides, veterinary drugs, mycotoxins and plant toxins at trace
concentration levels using U-HPLC coupled to single stage Orbitrap MS. As a result of this
study, it was concluded that the resolving power has to be fit-for-purpose, depending on
the matrix and concentration ratio of the analyte/coeluting matrix interferences. Usually, as
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much as 50,000 FWHM resolving power was required to separate the ions of the interest
from the interfering ions in order to achieve reliable and consistent mass assignments.
[122]

Similarly, a method employing U-HPLC with full-scan accurate mass MS for coccidiostat
drugs in animal feed extracts was found to produce false negative results when the mass
resolving power of the MS was insufficient to separate analyte ions from isobaric co
eluting sample matrix ions. [123]
A simple and rapid LC-MS method using accurate full-scan MS and MS/MS product ion
scan modes was developed and validated for screening cyclo-dopa and diketopiperazine
alkaloids in crude extracts of Portulaca oleracea L., an edible plant used as a folk
medicine in many countries, at sub-ppm levels. The alkaloids were identified based on
their MS/MS data, elemental compositions, and retention behaviour. [124]

2.4.3 Application of Orbitrap technology for metabolomics
Identification of metabolites and their biochemical relationship in complex mixtures can
also be made easier with a use of fourier transform Orbitrap MS. High mass accuracy
measurements, at ultra high mass resolution, for precursor and product ions enable
identification of molecular formulae and enhance the inference of biosynthetic
relationships between masses directly from the mass spectrum. [125]
The importance of mass resolution was investigated for analysis of hormone and veterinary
drug residues. UPLC-Orbitrap MS at a lower resolving power of 7,500 FWHM and UPLCTOF MS at mass resolving power 10,000 FWHM failed to detect all of the steroid esters in
hair extracts. However, using resolving power of 60,000 FWHM on an Orbitrap MS was
sufficient to mass resolve analyte ions from co-eluting isobaric matrix compounds and

30

enabled the detection and accurate mass measurement of all 14 steroid esters at low ng/g
concentration levels. [123]
Full-scan FT MS in the Orbitrap over the miz range 400-650, at a 30,000 FWHM
resolution setting, followed by data dependent MS and MS events performed in the LIT,
enabled development of a method for the determination of oxysterols in human plasma.
The developed methodology was also applicable to the analysis of other sterols in plasma,
including cholesterol, 7-dehydrocholesterol, and desmosterol, as well as cholesterol 5,65^c*o-sterols and steroid hormones. [126]
In another study, accurate mass measurements and the dynamic range provided by the
Orbitrap analyser, together with the sensitivity provided by LIT MS, enabled complex
information-rich metabolic fingerprints to be obtained in a few minutes by direct injection
of biological samples. Despite the absence of chromatographic resolution it was possible to
discriminate between isobaric ions thanks to accurate mass assignments of the product ions
and some of the isomers could be distinguish on the basis of diagnostics product ions in
their fragmentation spectra MS" generated in LIT MS. [127]
Hydrophilic interaction chromatography (HILIC), allowing polar metabolites to be retained
on the column, was shown to be effective in metabolite detection in complex extracts often
containing small organic acids and amino acids, nucleotides, carbohydrates, vitamins, and
lipids, especially when coupled to a high mass resolution mass analyser. [128] [129] [130]
UPLC-MS coupled with LTQ Orbitrap was used for the identification of large numbers of
metabolites based on accurate mass measurements, isotopic distribution, and MS/MS
information in biological samples, using both positive and negative ESI modes. [131]
Another fast method exploited the Orbitrap mass analyser equipped with an atmospheric
solids analysis probe (ASAP) for the direct analysis of ergosterol in a fungal pathogen with
minimal sample preparation. Rapid analyses of volatile or semi-volatile liquid or solid
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materials were possible using only slightly modified commercial ESI or APCI ion sources.
[132]
Increasing separation efficiency by using ultra-high pressure LC (U-HPLC) in combination
with Orbitrap MS detection has been demonstrated as well. [133] [123] To ensure
sufficient data points across narrow chromatographic peaks fast acquisition rates are
required, which is a distinct limitation when using ultra high resolution Orbitrap MS.

2.4.3.1 Drug metabolite analysis
During the drug discovery and development process there is a requirement for metabolite
identification at different stages. The presence of a large number of endogenous substances
in biological samples renders metabolite analysis very challenging. Therefore, most
analytical procedures require sample clean-up prior to analysis, which however can lead to
losses of some metabolites due to differences in chemical-physical properties. Reliable
identification and quantitation of these compounds in complex biological matrices can be
achieved once again with high resolution MS using narrow mass tolerance windows for
limiting the background signal, as has been demonstrated in several publications. [134]
[109] [135] The same approach, in combination with sequential MS" experiments, allowed
for characterisation of 14 phenobarbital metabolites in rat urine, some of which had not
been previously reported in the literature. [136] The identification of new human liver
microsomal mictabolites of carvedilol has been reported by the use of predictive mass
fragmentation software. Mass Frontier. [137] Structural characterisation of in vitro rat liver
microsomal metabolites of the antihistamine, desloratadine, was performed using online
hydrogen (H)/deuterium (D) exchange LC and high resolution MS. The structural
elucidation of metabolites was based on accurate mass assignments in both full-scan and
MS" mode. [138]
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Most scientific reports compare performance of different high mass resolution mass
analysers for accurate mass assignment to the analytes. Quantitative performance of fullscan high resolution MS methodology has been evaluated for several applications as well.
The analytical performance of the full-scan method on LTQ-Orbitrap was compared with
triple quadrupole SRM method for analysis of small molecules within preclinical
pharmacokinetic samples. Full-scan data were acquired at a 15,000 FWHM resolution
setting across an m/z range that included all analytes and potential secondary metabolites.
Comparable performance of methods was observed with respect to precision, accuracy,
sensitivity and linearity. [139] In another study, complete profiling and characterisation of
in vitro metabolites of the antidepressant agent, nefazodone, generated by human liver
microsomes was conducted using a Orbitrap MS with high mass accuracy measurements
for metabolite identification. These metabolites were initially analysed using triple
quadrupole (QqQ) MS instrument, but a reduced quality of isotopic pattern in the enhanced
mass scan was observed. Isotope information is useful for the elimination of possible
elemental compositions which, despite an excellent m/z match, are not consistent with the
isotope pattern. Moreover, spectral accuracy can indicate the presence of ion interferences.
The LTQ-Orbitrap maintained excellent isotopic pattern in full-scan mode and enabled the
detection and identification of 25 metabolites. [140] The ability of a mass spectrometer to
measure reliably the isotopic distribution of an ion, defined as spectral accuracy has been
investigated recently. Spectral errors were least at 7,500 resolving power (< 3%) and were
acceptable up to 60,000 resolution settings, but exceeded 10% for some compounds at a
100,000 resolution setting. The increased spectral error observed at higher mass resolution
(100,000 FWHM) for compounds with complex fine structure can be explained by the
phenomenon of isotopic beat patterns. [141] Correct measurement of isotopic pattern can
be used for triggering data-dependent product ion scans. A method that combined high-
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resolution accurate mass analysis with isotope pattern triggered data-dependent product ion
scans, for the simultaneous detection and structural elucidation within a single run using an
LTQ Orbitrap, was developed and validated for the analysis of glutathione conjugates.
[142] The

Br/ Br isotope ratio is also valuable in the search for metabolites in the

complex background of endogenous compounds. Data-dependent scanning using isotope
recognition in MS" spectra acquired using the LTQ-Orbitrap allowed structural
characterisation of the main metabolites of a new antituberculosis compound in methanolic
extracts of dog and rat faeces. [143] The selenol-p-hydroxymercurybenzoate complexes,
showing overlapped isotopic patterns of selenium and mercury, enhanced the identification
of selenols, key metabolites in the selenium pathway in selenium enriched yeast. [144]
Multiple tandem MS" allowed for the structural elucidation of a sulphated pentasaccharide
impurity in the drug fondaparinux. The most abundant [M-H]‘ ions were isolated using a
width of 2 m/z units and underwent CID fragmentation in LIT MS before detection in the
Orbitrap at a mass resolution of 100,000 FWHM. [145]
Mass spectrometric screening of metabolites results in complex data sets requiring
advanced data processing techniques for analysis to obtain satisfactory results. Acquired
data can be examined using various tools including, extracted ion chromatograms, massdefect filters, isotope pattern filters and neutral loss filters, which enhanced the discovery
of new metabolites. [146] [147] [148] [149] [150] [151]
Although the majority of the applications implement FTMS coupled to liquid
chromatography, a gas chromatography (GC) - LTQ Orbitrap MS method, capable of high
resolution (up to 100,000 FWHM at m/z 400) and sub-parts-per-million mass accuracy, has
been recently developed and used for the determination of polychlorinated dibenzo-pdioxins (PCDD) and dibenzofurans (PCDF) in environmental samples and the profiling of
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primary metabolites in Arahidopsis thaliana, a small flowering plant that is used as a
model organism in plant biology, extracts. [152]

2.4.3.2 Drug abuse control

The unequivocal identification of target analytes is given top priority in doping control
analysis. Unambiguous information required can be provided by high resolution/high
accuracy MS and diagnostic product ions generated from target analytes. The
understanding of dissociation pathways to characteristic product ions will allow for the
identification of novel drugs of abuse along with their metabolites, which is critical in the
area of drug testing and doping control.
Selective androgen receptor modulators (SARMs) represent an emerging class of non
steroidal anabolic therapeutics to counteract various diseases such as osteoporosis and
muscle wasting. Although not commercially available, their potential for misuse in
amateur and professional sports is high. As a consequence of this, these drugs were banned
as anabolic agents by the World Anti-Doping Agency effective from January 2008. Using
soft ionisation techniques such as ESI, protonated or deprotonated molecules of the
selected SARMs were generated. The CID of these precursor ions in MS/MS and MS"
experiments provided comprehensive structural information enabling the elucidation of
characteristic fragmentation pathways, which facilitated the identification of these
compounds, related substances and potential metabolic products in doping control samples.
[153] [154] [155] [156] [157] [158]
A growth hormone has been abused in sports for its performance-enhancing effects for
many years. Human insulin-like growth factor-1 (IGF-1) serves as a biomarker indicating
the misuse of human growth hormone. Diagnostic product ions of human IGF-1 were
characterised using full-scan MS and ESI-MS/MS experiments conducted on an LTQ
Orbitrap using a resolving power of 30,000 FWHM. [159] Similarly, high resolution
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tandem mass spectrometry was exploited to develop a method for analysis of acetylcholine
esterase inhibitors, growth-hormone secretion stimulators, and anabolic-androgenic steroid
stanozolol in urine samples. [160] [161]
Unambiguous identification of synthetic insulin analogues and human insulin metabolites
in urine and plasma was achieved by top-down sequencing-based approaches using both
low and high mass resolution instruments. [162]
Diagnostic product ions of Synacthein, a synthetic analogue of human adrenocorticotropin,
in human plasma were characterised using high resolution tandem mass spectrometry
employing an LTQ Orbitrap, operating in positive ionisation mode. [163] The same
approach has been used for determination of N-desmethyl and N-bisdesmethyl
sibutramine, active metabolites of antidepressant/antiobesity drug Sibutramine, in urine.
[164] CID MS/MS in positive and negative ionisation modes have been used to elucidate
the fragmentation pathways of efaproxiral, which enabled its incorporation into an existing
screening procedure for doping controls. [165]
Identification of proteases in doping control was accomplished using bottom-up
sequencing approaches based on in-gel digestion of separated enzymes followed by
capillary liquid chromatography-tandem MS" using Orbitrap MS. [166]
A selective method using high-resolution mass spectrometry with ion source fragmentation
and solid phase microextraction was developed for the determination of testosterone and
epitestosterone glucuronides in urine. [167]
Nano-UPLC coupled to an LTQ Orbitrap MS in combination with a triple quadrupole MS,
have been used for the determination of gonadotrophin-releasing hormone (GnRH). The
developed full-scan method allowed the determination of the non-degraded hormone in
human urine for doping control purposes. [168]
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Full-scan high mass resolution approach using in-source CID with an atmospheric pressure
chemical ionisation (APCI) source allowed the development of a new doping control
screening method for 29 banned compounds, including agents with antiestrogenic activity,
p2 agonists, exogenous anabolic steroids, and other anabolic agents in human urine. The
mass accuracy was found to be better at 2 ppm and the detection limit for all compounds
tested was better than 100 pg/ml. The developed method provided good sensitivity,
selectivity, specificity, robustness and a high throughput of samples, which make it a
valuable tool for analysis of drugs and metabolites in an antidoping laboratory. [169]

2.4.4 Lipid analysis
T he lipidome of eukaryotic cells consists of thousands of individual lipid species. It has
been demonstrated, using Saccharomyces cerevisiae as an example, that automated
shotgun lipidomics analysis enables lipidome-wide absolute quantification of individual
molecular lipid species. Absolute quantification of 250 molecular lipid species, covering
21 major lipid classes, was achieved by comparative lipidomics. [170]
Structural characterisation of lipids is a rather important application area for Orbitrap MS
technology. The LTQ Orbitrap MS was used for comprehensive and structure-specific
profiling of the molecular composition of sphingolipids and glycerophospholipids. Very
good mass accuracy (< 3 ppm), together with MS" acquisition, enabled the identification of
product ions specific for the amide-linked fatty acid and the long chain base moieties in
individual compounds. [171] Electrospray ionization (ESI) of positive and negative ions,
using an LTQ Orbitrap for MS and MS/MS analysis, allowed the assignment of the
distribution of the primary and secondary acyl residues of the intact lipid. [172] Boolean
scans and advanced interpretation routines enabled in-depth structural characterisation of
all detectable or preselected lipid precursors, which were fragmented using data-dependent
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MS/MS. [173] A top-down lipidomics screening strategy, employing rapid acquisition of
high resolution (100,000 FWHM) survey spectra, divided the entire pool of major lipids
into seven groups, which could be identified by accurately determined masses and CID and
HCD MS/MS experiments conducted using LIT MS and the C-trap respectively. [174] UHPLC coupled with high-resolution mass spectrometry allows unbiased profiling of
biological samples and simultaneous targeted analysis of specific compounds without
compromises. Simultaneous MS/MS data acquisition of phospholipids greatly enhanced
analytical specificity. But, at the price of reduced scan speeds when using higher mass
resolution (>50,000 FWHM) and is therefore not compatible with fast chromatography.
[175]
High resolution mass spectrometry was also used for the analysis of lipid extracts from
human carotid endarterectomy tissue. It was possible to characterise the changes observed
in phosphatidylcholine (PC) molecular species during in vitro oxidation of purified human
low density lipoprotein (LDL) and thus monitor the progression of coronary heart disease
and response to therapy. [176] Identification of oxysterols, the products of cholesterol
oxidation, in rat brain was enabled with the development of a highly sensitive (pg levels)
method. An LC-MS method using exaet mass analysis at high resolution was developed to
identify potential metabolites, and MS and MS experiments were performed to determine
the structure of novel metabolites. [177]
Top-down shotgun profiling on an LTQ Orbitrap MS, operating at 100,000 FWHM
resolution setting, for screening the plasma lipidome of 70 men, 19 of whom were
suffering with hypertension, demonstrated that hypertension is accompanied by specific
reduction of the content of ether lipids and free cholesterol. Therefore the developed
method enabled the establishment of a specific association between hypertension and lipid
profiles. [178]
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A method developed for the simultaneous profiling of more than 100 biochemically related
lipid mediators in biological samples was applied to the analysis of eicosanoid in chronic
lymphocyte leukemia (CLL) cells. The screening combined high-resolution tandem MS
analysis, together with isotope pattern and retention time matching, to reveal the presence
of 15 bioactive lipids. These belonged to a range of prostaglandin, leukotriene, and
hydroxy and epoxy fatty acid lipid mediators produced by chronic lymphocyte leukemia
cells. [179]

39

CHAPTER 3

Azaspiracids
(Review)

3.1 Azaspiracid shellfish poisoning (AZP)

3.1.1 Introduction
Azaspiracid shellfish poisoning (AZP) is the most recently discovered toxic syndrome
from shellfish consumption and a number of analogues belonging to this class of toxin
were identified in contaminated mussels. [180] [181] [182] [183] Following an incident in
1995 in the Netherlands, where at least eight people suffered severe gastrointestinal
difficulties, lasting several days, after consumption of mussels (M edulis) that were
cultivated in Killary Harbour in the west coast of Ireland. The main symptoms for acute
AZP intoxication include diarrhea, vomiting, stomach cramps and headache, which closely
resemble the symptoms associated with both DSP and bacterial enterotoxin poisoning.
However, the levels of those toxins in examined mussels were well below the regulatory
limit. [184] Within the next two years a new class of toxins was identified and named
azaspiracids (AZAs). [181] In following years all confirmed incidents of AZP were caused
by mussels cultivated in Ireland and AZAs have been detected in other European countries,
including the UK, Norway [185], France, Spain [186] and Denmark [83] and affected
species included oysters {Crassostrea gigcis), scallops {Pecten maximus), clams {Tapes
phillipinarium), cockles {Cardium edule) and razor clams {Ensis siliqua) [187] [188]. The
structural elucidation of AZAl revealed the significant difference from other polyether
marine toxins. AZAl possesses unique structural features, especially the fused ring system,
and it is an co-amino acid. [181] Subsequently, ten AZA analogues were found in mussels.
[182; 189] Toxicological studies have shown that AZAl can induce widespread organ
damage in mice and that they are potentially more dangerous than other classes of shellfish
toxins. Azaspiracids affect the liver, spleen, lungs, stomach and small intestine and it has
also been shown to be carcinogenic. [190; 191] An intraperatoneal (i.p.) mouse bioassay,
traditionally employed by most regulatory agencies for the detection of DSP and AZP
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toxins in shellfish, failed on many occasions to prevent human intoxications. This was not
only a consequence of poor sensitivity of the assay, but also of the fact that azaspiracids
are not exclusively found in the shellfish digestive glands that were used for toxin testing.
[192J

Following the severe intoxication outbreaks, a national surveillance programme,
employing LC-MS" methods for weekly monitoring of AZAs in shellfish, was initiated in
Ireland in order to prevent further incidence of AZP. [188] The Food Safety Authority in
Ireland (FSAI) established a provisional limit of 0.1 mg/kg in whole cooked mussel meat
in 2001. [193] The European Union EU decision of 2002 for the maximum levels and the
methods of analysis for various marine biotoxins in bivalve molluscs, echinoderms,
tunicates and marine gastropods [68], established a limit of 0.16 mg/kg for the combined
levels of AZA1-AZA3, that normally comprised 95% of the total AZAs in mussels, to be
determined by LC-MS methods. However, the application of these regulations has been
somewhat difficult due to the lack of reference standards necessary for implementing LCMS analysis.
Based on the currently available data the European Food Safety Authority (EFSA)
concluded that the current EU regulatory limit value for azaspiracid-group is not
sufficiently protective for consumers and therefore will be probably lowered. [194]
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3.1.2 Geographical occurrence and epidemiological impact of azaspiracids
Ljmited epidemiological data based on a small number of recorded human intoxications
due to shellfish contaminated with azaspiracid toxins made the determination of relevant
safety levels difficult. [194] This difficulty is a consequence of various factors, including
delays by the affected individuals in reporting poisonings to the relevant agencies,
uncertain or incorrect diagnosis, and problems in acquiring suspect samples post
consumption. [188] For these reasons AZP is probably more widespread than reported.
Ireland
Azaspiracids were discovered as a result of human intoxication that took place in
November 1995, when mussels from Killary Harbour, County Mayo, Ireland, (Figure 3.1)
caused severe gastrointestinal illness in the Netherlands. Clinical investigations involved
eight people who presented different digestive problems typical of DSP including nausea,
vomiting, severe diarrhea and stomach cramps. The shellfish that had caused the
intoxications had been cleared for export following testing of shellfish digestive glands
using a DSP bioassay and the water samples, collected in the same area, didn’t contain
Dinophysis acuta or D. acuminata, the phytoplankton associated with DSP toxicity in
Ireland. Bacteriological examination of samples confirmed, that none of the commonly
occurring pathogens, such as Streptococci, Staphilococcus aureus, Salmonella spp. or
Vibrio spp. was responsible for the illness. However, the rat bioassay, performed on the
samples weekly as well as DSP mouse bioassay, conducted on samples at the Central
Science Laboratory in Aberdeen, Scotland, gave strongly positive results. The mouse
bioassay suggested a “neurotoxin-like” response with mice survival time of approximately
90 minutes. [184] Since none of the known neurotoxins was detected in the sample, it was
concluded that an unknown toxic agent contaminated the mussels M. edulis and bulk of
mussel samples were subsequently collected from Killary Harbour for detailed
investigations, which lead to identification of a toxin, named spiroamino acid. [195] or
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Killary toxin-3 (KT-3) [180J. Satake reported the presence of another two toxins in the
sample extracts and named them KT-1 and KT-2. Structure elucidation revealed that
isolated toxin was polyether compound having two spiro ring assemblies, a cyclic amine
and carboxylic acid, was renamed, azaspiracid (AZAl). Mussels collected at Killary
Harbour in April 1996 contained 1.4 pg AZAs/g of total tissue and the toxicity in mussels
persisted for at least eight months. [181]
In October 1997, two years after the first intoxication event in the Netherlands,
consumption of mussels cultured in Arranmore Island, County Donegal, Ireland (Figure
3.1), caused gastrointestinal illness to at least 12 people of small island community that
recovered within 2-5 days. The analysis of a mussel sample confirmed that the causative
toxin was AZAl. [195] From mussels collected at Arranmore Island in 1997 two new
analogues of azaspiracid were isolated and structurally elucidated, azaspiracid-2 (AZA2)
and azaspiracid-3 (AZA3). The discovery of hydroxyl analogues, azaspiracid-4 (AZA4)
and azaspiracid-5 (AZA5), followed shortly afterwards. The total toxin levels in mussels
from Arranmore Island, determined by LC-MS, was higher than 30 pg/g HP. [182; 183]
Azaspiracids are not accumulated exclusively by mussels and oysters {Crassostrea gigas),
scallops {Pecten maximus), clams {Tapes philipinarium) and cockles {Cardium edule) can
also retain this group of toxins and accumulate them at levels comparable to those found in
mussels. The toxin profile in examined oysters was 1.55 pg AZAl/g, 0.8 pg AZA2/g and
0.1 pg AZA3/g, but AZA3 was not detected in most samples apart from mussels. Other
bivalve shellfish species contained only AZAl and AZA2 and the concentration levels
were much lower than in oysters. The highest levels of total AZAs recorded were 4.2 pg/g
in mussels, 2.45 pg/g in oysters, 0.40 pg/g in scallops, 0.20 pg/g in cockles and 0.61 pg/g
in clams, with cockles being the least affected. [196]
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Irish shellfish however, didn’t represent a danger exclusively to Irish consumers. During
September 1998, in Ravenna, Italy, there was a prohibition on the consumption of local
shellfish which were contaminated with yessotoxins. Mussels were imported from Clew
Bay, County Mayo, Ireland (Figure 3.1) and caused the poisoning of approximately ten
individuals. Subsequent analysis proved that typical DSP toxins were not present at levels
that could induce illness. The digestive glands of shellfish used for DSP protocols were
retained for chemical analysis. Liquid chromatography-multiple tandem mass spectrometry
'i

(LC-MS ) revealed the presence of AZAs in these mussels at a concentration of 1 pg/g.
[197]
Human intoxications in France, affecting up to 30 people, were caused by mussels
harvested in 1998 from Bantry Bay, County Cork, Ireland (Figure 3.1). These shellfish had
been qualified as “safe for human consumption” based on the regulatory DSP mouse
bioassay. However, up to 1.5 pg AZAs/g of total mussel tissue was determined in this
'I

smple using LC-MS methods. A distribution study of AZAs in the tissue compartments of
mussels revealed high content of AZAs in the other tissues, not only in the digestive
glands, where toxins usually accumulate. [198] The lack of confidence in regulatory testing
methods led to an embargo by France for most of 1999 of all bivalve shellfish originating
from Ireland. [188]
In August 2000, once again the mussels cultivated in the Bantry Bay, caused shellfish
poisoning to 16 people, that occurred throughout England, and included incidents in
Sheffield, Warrington, Aylesbury and the Isle of Wight. These shellfish had also passed the
DSP mouse bioassay before exported to the UK. [188] AZA1-AZA3 were identified in
these mussels by LC-MS^ analyses with levels of 0.85 pg AZAs/g of the remaining mussel
tissues. Different studies carried out have confirmed the sporadic contamination of
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shellfish from many other cultivation regions in Ireland, including Lough Foyle, Bruckless
and Kenmare Bay (Figure 3.1). [188]

lA>ugh Foyle

Figure 3.1. Map of Ireland showing some of the cultivation regions where azaspiracid
contamination of shellfish has been identified.

The most recent report of human intoxication from mussels cultured in Ireland was in the
U.S.A. in July 2008, where two people in Washington suffered severe gastrointestinal
difficulties after eating cooked and frozen mussels in garlic sauce. After reporting the
illness to the U.S. Food and Drug Administration, the mussels were analysed and 0.24 mg
AZ As/kg of a mussel tissue had been determined in mussels from the same lot. [199]
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United Kingdom
Azaspiracid poisoning had only been associated with mussels harvested in Ireland until
August 1998, when was this group of toxins was detected in mussels (M edulis) harvested
from Craster, in the north-east of England. Tested mussels gave a positive DSP mouse
bioassay, but the toxins typical of DSP were not present at levels efficient to cause such a
response. Using LC-MS methods, overall concentration of 0.13 pg AZAs/g of
hepatopancreas was determined in the retained samples. [185]
Norway and Sweden
The first identification of AZAs in Norway was in mussels (M edulis) cultured in
Sognetjord, in the south-west coast of Norway in, August-September 1998. The
concentration of 0.88 pg AZAs/g of the total tissue was determined using LC-MS analysis,
with majority of toxins retained in the hepatopancres. [185] The first closures of mussel
farming areas, in the fall of 2002, in the south of Norway were due to mussels (M edulis)
contaminated with AZAs above the regulatory limit. A year later, positive response in the
MBA, led again to the identification of AZAs in mussels. A full profile of AZAs using,
LC-MS/MS methods, was determined, including AZA6, the positional isomer of AZAl
and AZA7-AZA10, the hydroxylated analogues of AZAl and AZA6, that were previously
identified in contaminated mussels from Ireland. [200; 201] AZAs were also found to
accumulate in brown crabs {Cancer pagurus) in September 2005 and 2006, after The Food
Control Authority in Norway asked the Norwegian Scientific Committee for Food Safety
to undertake a risk assessment of AZAs in crabs. AZAs were previously detected by the
surveillance program of crabs established following a DSP intoxication episode in 2002.
Using LC-MS/MS and LC-MS" analysis, AZAl was determined to be the major
contaminant, detected also in white meat. Two locations were affected, Tjamo in Sweden
and the northern coastline of Norway. [202]
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Denmark
In 2002, 403 cases of diarrhetic shellfish poisoning were reported after consumption of
blue mussels (M edulis) in Antwerp, Belgium. The mussels were imported from Denmark
and contained high concentrations of okadaic acid. Although below the regulatory level
(0.06 pg/g), azaspiracid was also detected. [83]
France and Spain
Scallops

(Pecten

maximus)

from

Brittany

in

France

and

mussels

(Mytilus

galloprovincialis) harvested from Ria de Vigo in Galicia, Spain were found to be
contaminated with AZA1-AZA3 in 2003. The toxin profiles were similar to those reported
previously [187; 192] with total toxin content of 0.24 pg/g in Spanish mussels and the
digestive glands of French scallops contained 0.32 pg AZAs/g. [186]
Portugal
The survey carried out to determine the contamination of shellfish, including mussels (M
galloprovinciallis), cockles {Cerastoderma edule) and clams {Venerupis senegalensis),
between 2002 and 2003 in Portugal showed only very small number of shellfish contained
detectable levels of AZAl and AZA2. [203] The presence of AZAs in Portuguese shellfish
was confirmed in 2006. AZA2 was found to be prevalent toxin, followed by AZAl in
mussels (M galloprovinciallis), cockles {Cerastoderma edule), clams {Venerupis
senegalensis and Solen margitanus) and oysters {Crassostrea spp.) and only trace levels of
AZA3 were found in mussels. [204]
Morocco
The first report of azaspiracids in Morocco (NW Africa) and the first report outside of
European coastlines showed the presence of AZA2 as the predominant toxin, followed by
AZAl (13% to 26%). AZA3 was rarely detected in Moroccan mussels from the Atlantic
coast in 2004 and 2005. [205]
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Chile
I'he most recent occurrence of AZAs in Chile proves that AZP could be a worldwide
problem. The monitoring of AZAs in September 2008 in Coquimbo Bay northern Chile,
involved two bivalve molluscs, macha (Mesodesma donacium) and clam {Mulinia edulis).
Low levels of AZAl were detected in both species of shellfish. [206] Azaspiracids have
also been identified in mussels (Mytilus chilensis) and scallops (Argopecten purpuratus)
from two other Chilean locations. The areas studied were Bahia Inglesa and Chiloe
Archipelago, important scallop and mussels farming areas. In mussels, AZAl was the
predominant toxin in mussel hepatopancreas with AZA2, AZA3 and AZA6 present at
significant level also. Similar profiles were found in the remaining tissues. AZA2
predominated in the scallop samples with the toxin almost entirely present in the
hepatopancreas, while AZAl was identified only in some of the scallop samples and was
present at 12-15% of the AZA2 levels. [207]
Japan
Ueoka reported on the presence of AZA2 in Japan after isolation of this toxin from a
marine sponge, Echinoclathria sp., collected off Amami-Oshima. But no other AZAs were
reported to be present. [98]

3.1.3 Chemical structure and identification of azaspiracids
The structure of the first AZA discovered, AZAl (C47H71NO12, Mr 841.5), was reported in
1998 by Satake et al. after successful isolation of this compound from Irish blue mussels
(M edulis) tissues. [181] The elucidation of the toxin structure was carried out using oneand two- dimensional nuclear magnetic resonance (NMR) and high-resolution fast atom
bombardment mass spectrometry (FAB MS) and MS/MS experiments, which were
performed in positive and negative modes. The structure of azaspiracids is characterised by
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a series of fused polyether rings. The positive fragmentation spectra were dominated by
number of water-loss fragment ions [M+H-«H20]^. The negatively charged ion [M-H]'
underwent charge-remote fragmentation with the sequential cleavage of polyether rings,
which resulted in spectra rich in structurally informative ions. An azaspiro ring fused with
a 2,9-dioxabicyclo[3.3.1]nonane, a trispiro ring assembly, and terminal carboxylic acid
group gave rise to the name AZA-SPIR-ACID. [181]

Figure 3.2. a) Originally proposed structure for AZAl (incorrect) [208], b) revisited structure for
AZAl, confirmed by total synthesis [209].
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However, when the attempts to synthesize AZAl revealed different chromatographic
behaviour and discrepancies in NMR spectra between the synthesised compound and
AZAl isolated from natural sources, the structure was revisited. In 2003 Nicolaou et al.
proposed, after several degradation studies, a revised structure for azaspiracids (Figure
3.2). [209; 210]
There have been many approaches to the synthesis of some of these key structural elements
for AZAl, especially the ABCD ring system and the FGHI ring system. [211; 212; 213;
214;215;216;217;218;219;220; 221;222; 223; 224; 225]
The structures of several other groups of marine toxins, such as yessotoxins,
dinophysistoxins, brevetoxins and ciguatoxins, are also characterised by a series of fused
polyether rings. [226] However, AZAs have distinctive structural features that make them
unique within the nitrogen-containing marine toxins.
Shortly after the structural elucidation of AZAl, two new analogues, azaspiracid-2 (AZA2)
and azaspiracid-3 (AZA3), were isolated from mussels and their structure were determined
using NMR and negative ion FAB MS/MS experiments. [182]
The high resolution FAB MS suggested that the molecular formula of azaspiracid-2 was
C48H73NO12 ([M+H]^ m/z 856.5184, A -2.7 mDa), indicating an additional methylene or
methyl to the structure of azaspiracid. Further structural elucidation, carried out by
comparing the 'H-NMR data between azaspiracid-2 and azaspiracid, suggested that
azaspiracid-2 has a methyl substituent on C-8. The corresponding MS technique was used
to determine the molecular formula of azaspiracid-3, C46H69NO12 ([M+H]^ m/z 828.4889,
A -0.9 mDa), indicating that azaspiracid-3 lacks one methyl or methylene group in
azaspiracid. In the 'H-NMR spectrum of azaspiracid-3 the signal corresponding to methyl
on C-22 in azaspiracid was absent, therefore the structural confirmation of azaspiracid-3
was accomplished by comparing negative ion FAB CID MS/MS data with those of
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azaspiracid. The product ion spectrum from [M-H]' ion (m/z 826) of azaspiracid-3 showed
characteristic fragmentation and confirmed that azaspiracid-3 is 22-demethylazaspiracid.
[182] Nicolaou successfully synthesized and revisited the structure of AZA2 and AZA3 in
2006 (Figure 3.3). [227] AZA1-AZA3 are the predominant toxins in both mussels [197]
and dinoflagellates [198].
Using the same approach as for AZA2 and AZA3, the structures of two hydroxylated
azaspiracid analogues were determined after their isolation from mussel (M edulis) tissue.
The molecular formula for AZA4 and AZA5 was C46H69NO13 ([M+H]^ m/z 844.4857, A
-tO.9 mDa) and ’H-NMR spectra indicated that those two isomers are hydroxyldemethylazaspiracids. Studies of negative ion FAB CID MS/MS data confirmed AZA4
and AZA5 to be 3- and 23-hydroxy-22-demethylazaspiracid respectively (Figure 3.3)
respectively. [183]
So far, only structures of those five AZAs have been verified using NMR methods after
isolation from mussel tissue. The structures of other analogues, more than 20 are known to
day, have been proposed based on their mass fragmentation patterns.
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Figure 3.3. General structure of AZAs.
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3.I.3.J Mass fragmentation pathways of azaspiracids
The identification of new azaspiracid analogues has been achieved by establishing
characteristic cleavages in product-ion MS. Different types of mass analysers can be used
for this purpose. The sequential processes of mass fragmentation have been studied using
MS" data provided by quadrupole ion-trap (QIT) MS and linear ion-trap (LIT) mass
analyser incorporated in the LTQ Orbitrap MS and the latter for most the work that is the
subject of this thesis. Hybrid quadrupole time-of-flight (QqTOF) MS and Orbitrap mass
analyser, equipped with higher collisionally induced dissociation (HCD) cell provide high
mass accuracy data for precursor and product ions, which enhances confirmation of the
proposed formulae.
CID MS/MS spectra, in positive mode, display mainly product ions due to sequential water
losses from precursor and product ions. The base peak in the spectra is the product ion,
[M+H-H20]^, due to a facile water-loss that occurs at the geminal diol (C20-C21), forming
an epoxide (Figure 3.4). [228]

Figure 3.4. The fragmentation mechanism for A-ring cleavage of the [M+H-H2O]' ion in
azaspiracids, which results in the loss of the fragment containing the substituents R' and R^.
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Product ion spectra show a characteristic charge-remote fragmentation of the azaspiracid
skeleton with the strong tendency for charge to remain on the nitrogen during
fragmentation, which produces an ion series that is readily interpretable (Figure 3.5).
I'he ions produced by A-ring fragmentation (Figure 3.4), a facile retro Diels-Alder process,
are important diagnostic ions as they are usually abundant and the loss of R and R
substituents leads to product ions in MS" that can be used to distinguish between isomers.
There is a sequence of characteristic backbone fragmentations of the polyether skeleton of
azaspiracids, in addition to neutral losses of water molecules from the precursor and
product ions. The cleavage of the C-ring and the C19-C20 bond cleavage produce
diagnostic product ions containing the substituents R^ and R"^. The fragmentation of the Fa
ring and the C27-C28 bond results in the product ion, m/z 362 and 262 respectively,
fragment ion common for all known AZA analogues (Figure 3.5). Studies of mass
fragmentation pathways have led to identification more than 20 different naturally
occurring analogues of AZAl (Table 3.1).
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Figure 3.5. The MS^ spectrum of AZAl acquired using QIT MS. [229]

An isomer of AZAl, designated AZA6, has been tentatively assigned as 8-methyl-22demethylazaspiracid base on multiple tandem MS studies. [230] Similarly MS studies led
to the discovery of AZA7-AZA10 (Table 3.1), which are hydroxyl analogues of AZAl and
AZA6, together with AZAl 1, which is the 3-hydroxyl analogue of AZA2. [189] A number
of dihydroxy-, carboxy- and carboxy-hydroxy-analogues of AZAs have been found in
crude mussel extracts (Table 3.1). [231]
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Table 3.1. Overview of all reported AZA analogues.
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887.503107

AZA 17

carboxyAZA3

M

H

H

H

COOH

C47He9NO,4

871.471807

AZA 18*

carboxy AZ A1

CH3

H

H

H

COOH

C48H7INOI4

885.487457

AZA 19

carboxyAZA6

11

CII3

H

H

COOH

C48H7,N0,4

885.487457

AZA20*

carboxy AZA2

CH3

CH3

H

H

COOH

C49H73NO14

899.503107

AZA21

carboxy-3-hydroxyAZA3

H

H

OH

H

COOH

C47H69hJOi5

887.466721

AZA22*

carboxy-3-hydroxy AZA 1

H

CH3

OH

H

COOH

C48H7,N0,5

901.482371

AZA23

carboxy-3-hydroxyAZA6

CH3

H

OH

H

COOH

C48H7,NO,s

901.482371

AZA24*

carboxy-3 -hydroxy AZA2

CH3

CH3

OH

H

COOH

C49H73NO15

915.498021

^Estimated product, not observed in samples.

Structure
AZA25

21-22-dehydraAZA3

809.5

AZA26*

21 -22-dehydraAZA 1

823.5

AZA27*

21 -22-dehydraAZA6

823.5

AZA28*

21 -22-dehydraAZA2

837.5

AZA29

AZA3-1 -methyl-ester

841.5

AZA30

AZA 1 -1 -methyl-ester

855.5

AZA31*

AZA6-1 -methyl-ester

855.5

AZA2-1 -methyl-ester
AZA32
♦Estimated product, not observed in samples.

869.5
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3.1.4 Aetiology of azaspiracids
The highly oxygenated polycyclic ether structure of azaspiracid strongly suggested its
dinoflagellate origin, as is the case of other toxins with similar structural features. [232]
The heterotrophic dinoflagellate, Protoperidinium crassipes (Figure 3.6), was identified as
the progenitor of azaspiracids after individual cells from sampling were collected by hand
picking from microscope slides to produce monocultures. Azaspiracid-1, and its analogues,
AZA2 and AZA3, were identified in extracts of 200 cells using electrospray multiple
tandem MS. [233]

a)

Figure 3.6. Pictures of Protoperidinium crassipes, a) taken in Proteobio research group after
sampling under optic microscope, b) reproduced from www.nmnh.si.edu taken under electronic
microscope.

This phytoplankton genus was previously considered to be toxicologically benign and its
ability to accumulate considerable levels of azaspiracids was confirmed, however the
heterotrophic nature of these dinoflagellates needs to be taken into consideration, as they
are predators grazing on a wide range of prey items, including phytoplankton, copepod
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eggs, and early naupliar stages. Therefore, the role of Protopehdinium crassipes as a
vector, rather than progenitor, of azaspiracids should be considered. [233; 234; 235]
Recently, azaspiracids were detected in plankton net tows during a research cruise to the
North Sea. Size-fractionated plankton was analysed for AZAs by mass spectrometry and
small AZA-producing dinoflagellate was successfully isolated from the east coast of
Scotland. [236] It was demonstrated that an axenic culture of this dinoflagellate produces
AZAl, AZA2 and an isomer of AZA2. A small (12-16 mm length and 7-11 mm width)
peridinin-containing photosynthetic dinoflagellate, Azadinium spinosum (Figure 3.7), was
identified as a producer of AZAs. However the ordinal affiliation of the genus is uncertain.
[237]

»a)

2

Figure 3.7. Pictures of Azadinium spinosum, a) Light-microscopy view, b) SEM micrographs of

thecae of different cells taken under electronic microscope. [237]
Moreover, the most recently described dinoflagellate taxon, Azadinium obesum sp.,
isolated as clone 2E10 from the same locality as for Azadinium spinosum, produces no
known AZA analogues detectable by liquid chromatography coupled with tandem mass
spectrometry. Azadinium obesum is a small (13—18 mm length; 10—14 mm width)
photosynthetic dinoflagellate and can be morphologically distinguished from A. spinosum
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by slightly larger mean cell size, consistent absence of an antapical spine, the lack of a
stalked pyrenoid and several details of the plate configuration.
Based on the morphological

analysis, Azadinium is classified as a subclass

Peridiniphycidae of uncertain family and order affiliation. It thereby joins a large number
of other dinoflagellate genera of uncertain affinities. [238]
AZA2 was also isolated from the marine sponge, Echinoclathria sp., collected off AmamiOshima. [98]

3.1.5 Toxicological studies
3.1.5.1 In vivo toxicology

Initial tests, performed with DSP mouse and rat bioassays, gave strongly positive results
for mussel extracts contaminated with AZAs. [184] Mice, intraperitoneally (i.p.) injected
with mussel extracts, exhibited “neurotoxin-like” symptoms characterised by sluggishness,
respiratory difficulties, spasm, progressive paralysis, and death within 20-90 minutes.
Diarrhoea was not observed by i.p. injection. [180; 184; 239] The injection of a lethal dose
of partially purified AZAl (150 pg/kg) caused swelling of the stomach and liver, which
became yellowish and fragile, together with reduction, in the size and weight of the thymus
and spleen. [240] Observed pathological changes also included erosion and bleeding in the
stomach, vacuole formation and fatty acid accumulation in the hepatocytes, dead
lymphocyte debris in the thymus and spleen, and parenchymal cell pyknosis in the
pancreas which differed from those induced by other shellfish toxins. AZA2 and AZA3
displayed greater toxicity, for the minimum lethal dose was determined to be 110 and 140
pg/kg, respectively. [182] The hydroxylated analogues, AZA4 and AZAS, are less potent,
having lethal dose values of 470 and < 1000 pg/kg, respectively. [183]
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Mice administered orally with crude azaspiraeids (900 pg/kg) via gastric intubation did not
show any clinical change within 24 h. [240]
Mice administered pure AZAl did not show any behavioural change during first four
hours, even at the maximal dose of 900 pg AZAl/kg, and the p.o. lethal dose was
established to be 2.5 times higher than the i.p. lethal dose. Mice were divided into groups
and treated with single doses of AZAl ranging from 300 to 900 pg/kg. The mice
administered with the maximum dose were kept until death occurred. The autopsy showed
that azaspiracid causes fluid accumulation in the small intestine and the tissue injuries were
more severe in the upper part of the small intestine. The aceumulation of fatty droplets in
the liver, in addition to necrosis in the lamina propria of the small intestine and in
lymphoid tissues such as thymus, spleen and the Peyer’s patches, was observed also. The
weight of the liver was increased by 38% and the colour was changed from dark red to
pinkish red. Further observation included degeneration of hepatocytes, reduction of non
granulocytes and damage to T- and B-cells in the spleen. [241]
Chronic effects in mice caused by oral administration with sublethal doses revealed that
AZAl induced tumours in the lungs of mice as a consequence of repeated exposure to
toxin (20-50 pg/kg) over 20 weeks. All mice used in these studies developed interstitial
pneumonia and had shortened small intestinal villi, even at low doses (1 pg/kg).
Hyperplasia of epithelial cell was observed in the stomach of mice treated with 20 pg/kg
doses of AZAl. [191]
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3.1.5.2 In vitro toxicology
3.1.5.2.1 Teratogenic effect
Teratogenic potential of AZAl and its relevancy to toxin accumulation in finfish have been
evaluated via microinjection of purified AZA-1 in an embryonic Japanese finfish medaka
{Oryzia.s latipes). Microinjection technique was used to mimic the maternal-egg toxin
transfer of an AZAl reference standard and a shellfish extract containing azaspiracids in
medaka embryos. Substantial retardation in development such as reduced somatic growth
and yolk absorption, and delayed onset of blood circulation and pigmentation were
observed within 4 days of exposure at doses >40 pg AZA1 /egg. Embryos treated to >40 pg
AZAl/egg had slower heart rates (bradycardia) for the 9 days in ovo period, followed by
reduced hatching success. These studies demonstrate that AZAl is a potent teratogen to
finfish. [242] A general lack of egg yolk motility blood circulation and nutrient uptake
suggest a possible link to the effects of AZAs on the cytoskeleton, as proposed by Roman
et al.. [243] In addition, taking into account that Protoperidinium spp. are known to be
prey species for copepods and ciliates [244], it can be inferred that planktivores such as
fish may accumulate AZAs in their tissues.

3.1.5.2.2 Cytotoxicity
The studies, using cultured cells, demonstrate that azaspiracids can induce cytotoxicity and
affect several cellular processes depending on the effective concentration and the time
frames of responses.
Cytotoxic effect of azaspiracids to the hepatoblastoma (HepG2) cells and human bladder
carcinoma cells (ECV-304) were observed following a 24-h exposure of cultured cell lines
to a crude shellfish extract. [245] In the following years, using a variety of cell types from
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several mammalian sources, the cytotoxicity of azaspiracids was confirmed. The findings
of these studies were reviewed [235; 246] and are summarized in the Table 3.2.

Table 3.2. Summary of azaspiracid cytotoxicity
Cell line

Source

EC5o(nM)“

Method of analysis^

Ref

B lymphocyte

Raji

human

1.6*

MTT

[247]

Breast cancer

MCF-7

human

>1*

DNA content; cell number

[248]

Colon adrenocarcinoma*^

Caco-2

human

nd

DNA content

[248]

Colon adrenocarcinoma'^

Caco-2

human

nd

Alamar blue

[249]

HEK-293

human

4.6*

MTT

[247]

Cell type

Embryonic kidney
Hepatoblastoma

HepG2

human

unknown

MTT

[245]

Lung epithelial

A547

human

1.5*

MTT

[247]

Monocyte

THP-I

human

2.4*

MTT

[247]

Neuroblastoma

BE(2)-M17

human

nd

morphological

[250]

T lymphocyte

Jurkat,E6-l

human

1.1

G6PH

[251]

7 lymphocyte

Jurkat,E6-l

human

3.5

MTT

[247]

ECV-304

human

unknown

MTT

[245]

Cerebellar granule cells

primary

mouse

0.87

MTT

[252]

Cerebellar granule cells

primary

mouse

nd

LDH

[252]

Neuroblastoma

Neuro-2A

mouse

2.3*

MTT

[247]

Skin fibroblasts

primary

mouse

>10

DNA content

[248]

Spinal cord neurons

primary

mouse

nd

Action potencials

[253]

Pituitary epithelial

GH4CI

rat

16.8

MTT

[247]

Bladder carcinoma

Effective concentration resulting in 50% cell death at 24h. *EfTective concentration resulting in 50% cell death at 48h.
nd - not determined value; unknown - cytotoxicity induced by crude mussel extract
n', MTS and Alamar blue are mitochondrial enzyme-dependent viability assay. G6PH (glucose-6-phosphate dehydrogenase) and
LDH (lactose dehydrogenase) assay based on the release of these cytosolic enzymes from intact cell.
'^Human colon Caco-2 cells are not sensitive to AZAl induced cytotoxicity.
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3.1.5.2.3 Altered F-actin cytoskeleton
It has been shown that micro-molar concentrations of AZAl disrupts cytoskeletal structure
in human neuroblastoma cells (BE(2)-M17), inducing a time- and dose-dependent decrease
on F-actin (filamentous actin) pools on a non apoptotic manner. A link between F-actin
changes and diarrhoeic activity, reflecting the loosening of tight junctions in vivo, has been
suggested and this may be relevant to explain the severe gastrointestinal disturbance
typical of AZP. [243] F-actin rearrangement in human T lymphocytes (Jurkat cells) was
observed in an other study following 24 h exposure to a low concentration (10 nM) of
AZAl. [247] Subsequent studies, using various cell cultures, reported alternations in
cytoskeleton, however the cellular F-actin concentration was not affected, when using nM
concentrations of AZAl. [248; 250; 252]

3.1.5.2.4 Intracellular signalling molecules
Control of intracellular free calcium concentration [Ca^^]i is a critical component of
cellular homeostasis for all cell types and a sustained increase in [Ca^^]i concentration
induces cell death. Different studies have been performed on the effect of AZA1-AZA5 on
cytosolic calcium concentration [Ca ]i, cyclic adenosine monophosphate (cAMP-an
universal signal transducer) and cytosolic pFI (pH)i in human lymphocytes. It has been
observed that while AZAl and AZA2 increase [Ca^^]i and cAMP levels by activation of
calcium release from intracellular stores, and influx of Ca

from extracellular medium

[243; 254] AZA3 does not empty intracellular stores, but also increases cytosolic calcium
concentration and cAMP levels [254]. Although AZA4 did not induce Ca -influx,
inhibition of the basal pFl increase was observed. AZA5 does not modify intracellular
homeostasis at all. [255; 256] Differences in the effects on the modulation of intracellular
calcium and pFl caused by azaspiracid analogues has been assigned to differences in their
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structure which correlate with in vivo toxicity experiments, showing that AZA4 and AZA5
are much less toxic than AZA1-AZA3. [183] However, Twiner et al believe that this
would be quite unusual for toxins, that arc structurally so very close, and the differences in
inhibition of completely different mechanisms of action could be a result of different
solubility and purity of toxins. [235]

3.1.5.2.5 Membrane proteins
Effects of AZAs on the membrane proteins, claudins, integral to tight junction cell
adhesion, and cadherins, transmembrane adherens proteins involved in cell-to-cell
adhesion, have also been investigated in recent years. It was found that nano-molar
concentrations of AZAl caused a decrease in human breast cancer (MCF-7) cell
proliferation and impaired cell-cell adhesion, due to the fragmentation of the E-cadherin.
AZAl (0.47nM) altered the cellular pool of the adhesion molecule E-cadherin by inducing
a dose- and time-dependent accumulation of an E-cadherin fragment. It seems that the
toxin effect is cadherin-specific, since treatment of fibroblasts with AZAl did not affect
the cellular pool of N-cadherin. [248]
AZAs were found to be weakly bound to proteins within the hepatopancreas of
contaminated mussels, M.edulis. Protein with a molecular weight of 45 kDa was more
abundant in contaminated mussels, than in blank samples, and another a 22 kDa protein
was present only in contaminated shellfish. [257]
In another study, conducted on T lymphocyte cells treated with AZAl, analysis of gene
expression patterns using whole human genome microarrays revealed several biological
pathways including cholesterol and fatty acid synthesis. Reduced intracellular levels of
cholesterol were associated with up regulated expression of the LDLR (low density
lipoprotein receptor) that is typically involved in regulating the level of cholesterol in the
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blood. This receptor binds with low-density lipoproteins and endocytoses cholesterol
bound to low density lipoproteins into the cell. [251]

3.1.6 Methods for analysis of azaspiracids.
3.1.6.1. Bioassays

Initial attempts to monitor azaspiracids relied exclusively on non-selective mouse or rat
bioassays, which had been developed to monitor DSP toxicity in shellfish. [75; 258]
However, the poor sensitivity of these methods for detecting AZAs and the fact that only
the digestive glands of shellfish was tested, led to several acute human intoxications
incidents. Unlike polyether toxins belonging to the DSP group, which accumulate almost
exclusively in the digestive glands (hepatopancreas) of shellfish [65], azaspiracids were
found to be distributed through all shellfish tissue. [187; 192] Therefore, the failure to use
all shellfish tissues for bioassay resulted in false negatives and subsequent incidents of
intoxications from the consumption of shellfish. [197] Not only does the mouse bioassay
suffer from poor reproducibility but the lack of specificity fails to identify the false
positives caused by the presence of free fatty acids in the shellfish extracts. [259] After a
recent attempt to evaluate the performance of the mouse bioassay (MBA) it was concluded
that MBA performs just as well as LC-MS/MS at the current regulatory limit (0.16 mg/kg)
for AZAs in shellfish. Quantitation of AZAs in the mussel tissue homogenates was
achieved using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS)
technique. Although extracts from the hepatopancreas (HP) from cooked mussels were
diluted with HP extracts of raw non-contaminated shellfish to take into consideration the
contamination of the other shellfish tissues [260], there is a considerable variability in the
toxin profile from one shellfish to another (unpublished data) and considering the presence
of other possible diarrheic agents in the sample, more specific method should be employed
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for analysis of AZAs in all shellfish tissue. Moreover, as demonstrated in Chapter 5 of this
thesis, the profile of the toxins in uncooked shellfish tissues varies greatly from that found
in cooked shellfish tissues.

3.1.6.2 Liquid Chromatography-Mass Spectrometry
Liquid chromatography coupled with mass spectrometry (LC-MS) has several major
advantages over the MBA method. First of all the LC-MS technique is a highly sensitive
and specific method, enabling for the quantitation and analyte confirmation in rather
complex shellfish tissue extracts. Automated fast analytical runs allow for rapid screening
of samples, providing results rapidly. The employment of single stage MS, single
quadrupole MS, for analysis of polyether marine toxins in shellfish tissue encountered
dilTiculties in form of ion suppression/enhancement by interfering matrix components.
1261] To overcome this problem, solid phase extraction (SPE), a cleanup step prior the
analysis, was undertaken to reduce the interferences and enhance the sensitivity and
reliability of the method for the determination of AZAs in shellfish. [232] Moroney et al.
compared several types of SPE cartridges for cleanup efficiency of shellfish matrix, and
based on the recovery and reproducibility data identified the most suitable octadecyl (Cig)
and diol SPE for AZA analysis. [262]
Tandem MS (MS/MS, MS") provides sufficient structural information to allow
unambiguous identification of AZAs in marine samples. The collision induced dissociation
(CID) spectra acquired on the triple-quadrupole (QqQ) MS provide very good structural
information due to the backbone cleavages of AZAs structure.
A quadrupole mass analyser with electrospray ionization (ESI) source was used to develop
first method for determination of azaspiracid and its two analogues (AZA 1-AZAS) and
applied for confirmation of AZAs in toxic mussels M.edulis collected at Arranmore Island,
Ireland in 1997. Protonated ions [M+H]^ m/z 842.5 for azaspiracid, m/z 856.5 for
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azaspiracid-2 and m/z 828.5 for azaspiracid-3 were monitored via selected ion monitoring
(SIM). [232]
The first micro liquid chromatography-tandem mass spectrometry (micro-LC-MS/MS)
method for the determination of AZAs in mussels was developed using QqQ mass analyser
equipped with atmospheric pressure ionisation (API) source in positive mode. Multiple
reaction monitoring (MRM) experiments and three product ions, [M+H - a7H20]^ with n =
1-3, were identified for toxin confirmation. [263] MRM involves the selection of a
precursor ion and its product ion formed using CID fragmentation, and it is very selective.
However, MRM transition based on successive water losses [M+H - ^H20]^ from the
precursor ion [M+H]^ are not structurally diagnostic and full chromatographic resolution
of AZA isomers is required. Therefore monitoring the product ions resulting from the
backbone fragmentation, providing diagnostic product ions, is more important for
compound confirmation. In following years, several methods for the determination of
AZAs in shellfish using a triple-quadrupole instrument were developed. [264; 265]
UPLC coupled to a hybrid triple-quadrupole/linear ion-trap mass spectrometer was
recently used for identification of known and new azaspiracids in mussels (M edulis).
[231 ] In this study, MRM targeting product ions resulting from fragmentation of E-ring of
azaspiracids was carried on, in the belief detecting all azaspiracid analogues present in the
sample, since fragment ions produced by this cleavage have been observed in the CID
spectra of all known AZAs. However, as demonstrated later in Chapter 6 of this thesis, the
above approach fails to detect azaspiracid metabolites that differ in substituents bound to
the remaining rings of the product ions resulting from E-ring and C27-C28 cleavage.
LC-MS^ methods proved to be particularly effective for the rapid determination and
discovery of new AZA analogues using a quadrupole ion-trap (QIT) mass analysers (LTQ,
Thermo Finigan). [189; 230; 265; 266] The fragmentation of the A-ring in the azaspiracid
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structure, enabling the selection of unique precursor-product ion pairs [M+H]^
H20]^

[M+H -

[M+H - H2O - A-ring]^, facilitated development of selective method for

determination of eleven azaspiracids (including isomers AZA1/AZA6, AZA4/AZA5 and
AZA7/AZA8/AZA9/AZA10) without the need for complete chromatographic separation.
[189; 267] QIT MS does not achieve the detection limits that can be obtained by MRM
using a triple-quadrupole mass analyser. However, LC-MS using the QIT MS has been
shown to be more sensitive than LC-MS/MS for determination of azaspiracids, due to the
trapping process that reduces background noise so that the signal/noise (S/N) is increased.
Table 3.3 shows unique precursor-product ion pairs used for distinguishing azaspiracid
analogues by multiple tandem MS.

Table 3.3. m/z ratio of the parent and major fragment ions of 12 azaspiracids.
Toxin

[M+Ht

IM+H-H20t

/M+H-H20-A-ring/^

AZAl

842.5

824.5

672.4

AZA2

856.5

838.5

672.4

AZA3

828.5

810.5

658.4

AZA4

844.5

826.5

658.4

AZA5

844.5

826.5

61AA

AZA6

842.5

824.5

658.4

AZA7

858.5

840.5

672.4

AZA8

858.5

840.5

688.4

AZA9

858.5

840.5

658.4

AZAIO

858.5

840.5

eiAA

AZAll

872.5

854.5

672.4

AZA12

872.5

854.5

688.4
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Hybrid quadrupole time-of-flight mass spectrometry (QqTOF MS), equipped with ESI,
was exploited for the elucidation of fragmentation pathways of azaspiracids. [268; 269;
270] High mass accuracy data were obtained for all precursor and product ion resulting
from backbone fragmentation of azaspiracids structure, enhancing the confidence of
structural elucidation. The configuration of QqTOF MS can be regarded to as the addition
of a mass-resolving quadrupole and a collision cell to an ESI-TOF, which make them
powerful and robust instruments with unique capabilities, combining high sensitivity, high
resolution and high mass accuracy for both precursor (MS) and product ions (MS/MS)
modes. The mass accuracy reached in the previous studies for identification of product ions
from azaspiracids under CID fragmentation, using high mass resolution QqTOF
instruments, was however not sufficient for an unequivocal determination of the molecular
formulae of the formed product ions. [231; 268] fhe differences of the measured m/z ratios
from the theoretical values reached for some of the product ions had ppm error greater than
50, which resulted in 5 - 10 possible elemental formulae. [268] This was due to the low
sensitivity of measurements using QqTOF mass analysers, which is a consequence of
inability of these instruments to satisfactorally resolve the ions of the interest from isobaric
background ions, in the matrix.
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CHAPTER 4

Application ofHybrid Linear Ion-trap
Orbitrap Mass Spectrometry for the
Determination of the Polyether Toxins,
Azaspiracids, in Shellfish

4.1 Introduction
The majority of the AZP incidents occurred following the consumption of shellfish, which
were cultivated along the western coast of Ireland. [188] The official method for the
control of AZAs in shellfish was a non-validated mouse bioassay (MBA) but this
repeatedly failed to prevent AZP outbreaks. This was not only a consequence of poor
sensitivity and poor selectivity of the MBA, but studies of toxin distribution in mussels
demonstrated that AZAs were present in the other parts of shellfish tissues and not
exclusively in digestive glands. [192] The development of liquid chromatography-multiple
tandem mass spectrometric (LC-MS/MS, LC-MS") methods for the determination of AZAs
in shellfish [230; 264; 266] led to their detection in other countries. Azaspiracids (AZAs)
are co-amino acids with complex polyether rings (Figure 3.3). More than 25 AZA
analogues have so far been identified in shellfish using MS methods but only five of these,
AZA1-AZA5, have been isolated and fully structurally elucidated. [189; 231] AZAl AZA3 are the predominant toxins found in mussels and they differ from one another by
methylation at C8 (on the A-ring) and C22 (on the E-ring). AZA4 and AZA5 are the 3- and
23-hydroxyl analogues of AZA3 and AZA6 is an isomer of AZAl, with a methyl group at
C22 (Figure 3.3, Table 3.1). [183; 229] Previous methods for the determination of AZAs in
shellfish have employed quadrupole ion-trap (QIT) and triple-quadrupole (QqQ) mass
analyzers with hybrid quadrupole time-of-flight (QqTOF) MS for structural confirmation.
[228; 231; 270] Until recently, AZAl was commercially available and to obtain other AZA
standards it is necessary to purify these compounds from contaminated shellfish using
protracted isolation procedures. [182; 271] Therefore, analytical methods for the
determination of AZAs not only require high sensitivity, as they are trace contaminants,
but also high specificity is required confirm the identity of toxins for which standards are
not available. Multianalyte analysis is frequently performed using LC-MS/MS with a
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triple-quadrupole (QqQ) analyser, using multiple reaction monitoring (MRM), performed
with two or more precursor-product ion pairs per analyte. Although this is highly selective
and yields precise quantitative data, there are disadvantages inherent in targeted MS
methods, not least of which is the failure to detect analogues and bioconversion products
that have not been pre-selected. The main advantage of full-scan analysis is that there are
no targeted measurements and data are analysed using post-acquisition data analysis. [122]
High mass resolution, with high mass accuracy, meets these requirements and most
published methods have involved environmental and food analysis using TOP MS.
Examples include the detennination of pesticide residues in vegetables, fruit juices and
water. [272; 273; 274] Analysis of very complex samples, in which there are a large
number of matrix components at concentration levels much higher than those of the
analytes, requires very high mass resolution with narrow mass isolation windows. [117]
The LTQ Orbitrap, a hybrid instrument with a linear ion-trap (LIT) mass spectrometer
linked to a high-resolution fourier transform (FT) mass spectrometer, was exploited to
perform non-target high-resolution full-scan MS analysis with simultaneous targeted CID
MS/MS. Using the highest mass resolution setting (100,000 FWHM) in full-scan mode, the
methodology was validated for the determination of six AZAs in mussel (Mytilus
galloprovincialis) tissue extracts. Ultra-high mass resolution, together with a narrow mass
tolerance window of ±2 mDa, dramatically improved detection sensitivity.

70

O
rs

X 00 c
i -c

E

3

a

CN
ON
w.

TjNO

NO
—'

00

oo

NO

(N
t-NO

La

—
(N

r'
(N

or-o«rj'^fs'^f^o-N‘n'o
rn

—

+ ^ U, O
w l-

■o

On
w

NT)
NO

NO

NO

9

00

V-)
NO

U

s
u

o

O
(N
3: ^

£

s

”c5
CJ

NO

NO
*—'
»—

w
Si

"T 6fl
-i- c o
+ -r- (U

a.

£.< H

oi
r'
NO

oi

04
On

OO
O'
o

NO

«o
NO
ON
rn
od
<o
NO

>o
»o
On
ro
od
«o
o

<o
»o
ON oo
04 f'
o o

m
04
«r)
00 t'
'cr
o
1 NO
04
OO

04

r'
NO

IT)
>o
On
fO
od
«o
NO

04
m
On
O
o NO
04
OO

OO
ON
o On
04
o
04
OO

o
On
fO

a
JS

M
X
I
DC
+

Vi
Vi

"O
c
3
o

E

E
Q.
O.

u

o>
04
OO

o >o
o od
fO
oo

oo

&

3
»ri
o

T3
S
3
"E
%»*

o
(U
JZ
H

Q
U
X

U
o
lb

^

a

3

U
CA
■<—

DC c
i o
S cZ
' w

a
»o
^
u

O
NO

00

ON

o

'--I

J3

ON
tN

ro
<0

O'

ON

04

NO
04

04

OO

OO

OO

—>
ON

CO
04

04
O

NO

<=>o3^2n?®»^?SS®®S'^ND
04 ® NO
oi^No^odi-^'^Tj-'^oi®
—■
Tj>0
04
oo
oo
oo
00
-oo
oo

3

3
N

<
U

a
Vi

C
o

-o
B
9^
o.
9>
t3
I

■o
B
a>

3
»3
£

C/5

a

3
H

00

04
>o
NO
>o
00

Oi

X

fti

ct;

3
3

-C
H

O
OO
ON
oo

04
O

04
O'

OO

OO
rf"

yn
yn
o
in
oi
■Nit
OO

od
04
00

oo

oo

DC

3:

3:

3:
o

3:

X

X

3:

X
o

3:

3:

X
U

cn
3:
u

3:

3:

3:

3

3:
u

3:

3:

3:

CO
3
U

04
<

fo
<
SI
<

<
SI
<

<

NO
<

<

<

-o
OX)
_B

WJU
M)

o
*o
o
V)
04

g
■3
9>
B
s
u
9>
9>
•o
B
O

X

•3
O
)L.
a

<
N
<

In addition to employing chromatographic resolution to distinguish between the isomeric
azaspiracid analogues, AZA1/AZA6 and AZA4/AZA5, higher energy collisionally induced
dissociation (HCD) fragmentation of selected precursor ions were perfomied in parallel
with full-scan FTMS. Using HCD MS/MS, most precursor and product ion masses were
determined within 1 ppm of the theoretical m/z values throughout the mass spectral range
and this enhanced the reliability of analyte identification. For the analysis of mussels (M
galloprovincialis), the method limit of quantitation (LOQ) was 0.010 pg/g using full-scan
FTMS and this was comparable with the LOQ (0.007 pg/g) using CID MS/MS. The
repeatability data were; intra-day RSD% (1.8-4.4%; n=6) and inter-day RSD% (4.7-8.6%;
n=3). Application of these methods to the analysis of mussels (M edulis) that were
naturally contaminated with azaspiracids, using high-resolution full-scan Orbitrap MS and
low-resolution CID MS/MS, produced equivalent quantitative data.

4.2 Experimental section
4.2.1 Materials
For method development and validation, azaspiracid standards were prepared by isolation
from contaminated mussel (M edulis) tissues using multiple chromatographic separation
procedures similar to those described previously. [182; 271] These steps included a diol
solid phase extraction, size exclusion chromatography, reversed phase (Cig) solid phase
extraction and repeated reversed phase (Cig) preparative liquid chromatography. The purity
of isolated toxins were verified using full-scan FTMS and were quantified using a certified
reference standard AZAl (CRM-AZAl, NRC, Canada). All solvents including acetone,
ethyl acetate, HPLC grade water, methanol and acetonitrile were purchased from Fisher
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Scientific (Dublin, Ireland). Trifluoroacetic acid (TFA) an< anonium acetate (SigmaAldrich, Dublin, Ireland) were used as mobile phase modifies.
Blue mussels {Mytilus edulis), naturally contaminated wit] a;piracids, were obtained
from

County

Donegal,

North-West

Ireland.

Meditrr^n

mussels

{Mytilus

galloprovincialis), obtained from south coast of Sardinia, Ita were used for method
validation studies. Mussels {M. edulis) were dissected into th^esue compartments, gills,
hepatopancreas (HP) and the remaining tissues (RT). Each tisuompartment (0.5-1.0 g)
was homogenised (Ultra Turrax, IKA, Germany) with acetoe (nL) in a centrifuge tube
(50 mL) for 1 min, followed by centrifugation at 704 g(30 rpm) for 3 min. The
supernatant was transferred to a volumetric flask (10 mL), he;traction procedure was
repeated, combined with the first extract and made up to 10 nL ^h acetone. An aliquot (1
mL) was evaporated using nitrogen at 20 °C (TurboVaj, ziark, MA, USA). The
remaining residue was extracted using ethyl acetate (2x2 rr_.) d the combined extracts
were evaporated using nitrogen. The residue was reconstitmd methanol (200 pL) and
used for LC-MS analysis.
To ensure toxin-free shellfish tissues, mussels (M galloprvmlis) were depurated in
seawater for three months with a daily feed of ‘Instant

Shellfish Diet’ (Reed

Mariculture Inc., Cambell, CA, USA), together with a 10 % ailyawater change.

4.2.2 LC conditions
Chromatographic separations were carried out using an vcq LC system (Thermo
Scientific, Hemel Hemstead, UK), equipped with a Security ju: cartridge (Cig, 4.0 mm
X 2.0 mm, Phenomenex, Macclesfield, UK) with a reversed-paanalytical column (Luna
Ci8(2), 3pm, 150 X 2 mm; Phenomenex) maintained at 35

Tlinjected sample volume

was 5 pL. The isocratic elution employed water and acetonitile2:58, % v/v) containing
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0.05% tritluoroacetic acid (TFA) and ammonium acetate (1 mM), w rate of 200
laL/min. During the first minute, the eluate from the column was div< waste and the
chromatography was terminated at 15 min.

4.2.3 Mass spectrometry optimization and calibration
The LC system was connected to a hybrid LIT MS-FT mass spectre LTQ Orbitrap
XL, Thermo Scientific), with a heated electrospray interface (H-ESI)ing in positive
ionisation mode. All ion source tune parameters were optimised ly by infusing
AZAl standard (0.5 pg/mL) and monitoring the ion at m/z = 8M+H]^). This
optimisation was carried out until no precursor ion fragmentatioobserved. The
optimised parameters for H-ESI source are summarized in a Table

Orbitrap MS

was calibrated using a solution containing L-methionyl-arginoyolalanylalanine
acetate H2O (MRFA), caffeine and pertluoroalkyl triazine Ultramai, according to
the manufacturer’s instructions. For the determination of azasj. the method
consisted of three scan events; a) full-scan FTMS (Orbitrap XL), b) MS/MS datadependent scan, using HCD, to monitor all AZA analogues (Ta) and c) CID
MS/MS, with four precursor and product ion pairs (Table 4.1), usiLIT MS. One
micro scan was applied for all experiments with a maximum injection>r FTMS of 10
ms for full-scan MS. The maximum injection time for MS/MS scanh the LIT MS
and FTMS was 100 ms. Full-scan MS were acquired as profile datata-dependent
MS/MS spectra were acquired with optimized relative collision emCE) of 38 %,
using an isolation window of 2 Da in centroid mode. The mass on was set at
100,000 (FWHM) with a mass range of 100 - 900 m/z in the Orbitryser. The lock
mass option was employed by recalibration of the mass scale using values of two
selected ions, [M+Na]^ from TFA and [M2+^^Cu]^ from acetonitrile. 9 MS/MS data
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were obtained at low-resolution, as centroid data, in the LIT MS. An optimised 33 % RCE
was used, with an isolation window of 2 Da, to produce abundant [M+H-H20]^ ions (Table
4.1). Operation of the entire LC-MS instrumentation was controlled using Xcalibur
software (Thermo Scientific).

Table 4.2. Optimised H-ESI Parameters

The parameter
Ion transfer tube temperature (°C)
H-ESI probe vaporizer temperature (°C)
Sheath gas flow (arbitrary units)
Auxiliary gas flow (arbitrary units)
Source voltage (kV)
Capillary voltage (V)
Tube lens (V)

275
50
35
30
4.5
47
160

4.2.4 Post-column infusion to assess matrix effects

AZAl standard solution (0.3 pg/mL) was infused into the chromatographic eluate prior to
entry into the H-ESI source of the instrument. Two injections (5 pL) were performed and
repeated three times; i) LC water and ii) an extract from mussel tissues (AZAl toxin free).
The AZAl standard solution was introduced, using a 1 mL gastight syringe (Hamilton,
Birmingham, U.K.) and a syringe pump (Harvard Apparatus, Holliston, MA, USA), at a
flow rate 50 pL/min into the LC eluent, using a T-junction conection. The ion at m/z 842.5,
corresponding to the [M+H]^ ion of AZAl, was monitored for 20 min.
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4.3 Results and discussion
Coupling linear ion-trap (LIT) and Orbitrap FT mass analysers greatly facilitates the task
of analyte identification because it enables parallel data acquisition on two mass analysers.
Ultra-high-resolution and accurate mass measurements, using narrow mass tolerance
windows, help resolve and identify analytes from background matrix ions with increased
sensitivity due mainly to the reduction in background signal. [123] The advantage inherent
in using this hybrid instrument configuration is the ability to perform quantitative non
target analysis using full-scan FTMS and simultaneously use targeted MRM analysis in the
LIT mass analyser. Sample clean-up, such as SPE, cannot readily be applied in non-target
analytical methods due to unpredictable losses of analytes but it may be necessary to use
SPE to improve detection limits. [273] A full-scan MS method must therefore have
sufficient sensitivity to satisfy stringent legal residue limits as well as yielding accurate
quantitation, together with confirmation of analyte identities.

4.3.1 Fragmentation studies of azaspiracids using HCD MS/MS
In previous studies, separate MS instruments were used to elucidate the major CID
fragmentation processes of azaspiracids. Thus, MS" studies were performed using
quadrupole ion-trap MS instrument, and high-resolution MS/MS was achieved using
QqTOF MS to give high mass accuracy precursor ion and product ion data for three
azaspiracids, AZA1-AZA3. [228; 231; 270] In common with most polyether marine
toxins, the CID spectra of these compounds display mainly product ions due to sequential
water losses.
The base peak in the MS/MS spectra is the product ion, [M+FI-Fl20]^, due to a facile water
loss that occurs at the geminal diol (C20-C21), forming an epoxide as shown in the insert
in Figure 4.1. [228] The HCD using the LTQ Orbitrap MS is an alternative MS method
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that employs an additional collision cell situated at end of the C-trap region. [Ill] HCD is
valuable for the generation of low-mass diagnostic product ions in MS/MS mode, and can
also be used in combination with CID in LIT MS for MS" experiments. The product ion
spectrum (Figure 4.1) of AZAl was produced using HCD MS/MS. While all the major
product ions in the CID spectra (not shown) were also observed in the HCD spectrum, the
latter contains additional ions, especially in the lower m/z region.

824.49511

Figure 4.1. The FTMS HCD spectrum for AZAl, from fragmentation of the ion, m/z = 842,
[M+H]^. The accurate masses for ions are shown with the error differences (ppm) from calculated
values in bold. The insert scheme shows the main fragmentation processes involving the [M+HH20]"^ product ion, m/z = 824.
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Importantly, HCD effectively eliminates the low-mass cut-off, a drawback typical of most
ion-trap mass analysers. Using an optimised relative collision energy (RCE) allowed a
portion of precursor ions to remain in the HCD spectrum of AZAl (Figure 4.1). High mass
accuracy data were acquired for all precursor and product ions and the mass accuracy data
were usually within 1 ppm of the theoretical m/z values and were consistently within 3
ppm. Evident in this spectrum (Figure 4.1) are product ions that are characteristic of
charge-remote fragmentation of the azaspiracid skeleton and the strong tendency for the
charge to remain on the nitrogen atom during fragmentation produces an ion series that is
readily interpretable. [270] There are at least six characteristic backbone fragmentations of
the polyether skeleton of azaspiracids, in addition to neutral losses of water molecules from
the precursor and product ions. The six azaspiracids used in this study were AZA1-AZA3
and AZA6, which differ from one another by methylation at C8 (A-ring) and C22 (E-ring),
and AZA4 and AZA5 which are analogues of AZA3, with hydroxyl moieties at C3 and
C23, respectively (Table 4.1). The ions produced by A-ring fragmentation, a facile retroDiels-Alder process (Figure 3.4), are especially important diagnostic ions as they are
usually abundant and the fact that the substituents,

and R'^, remain whilst R' and R^ are

lost, leads to product ions in MS" that can be used to distinguish between isomers. [270;
275] Thus, the isomers with precursor [M+H]^ ions at m/z 842, AZA1/AZA6, gave
different product ions, [M+H-H20-C9Hio02R*R^]^, at m/z 672 and 658, respectively.
Likewise, the isomers with precursor [M+H]^ ions at m/z 844, AZA4/AZA5, have different
product ions due to A-ring fragmentation at m/z 658 and 674, respectively (Table 4.1).
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4.3.2 LC-MS method development
Simultaneous targeted and non-target methods for the determination of AZAs in shellfish
tissues were developed and the data produced were compared for six azaspiracids, AZAlAZA6. Three scan events were performed: a) fullscan FTMS, at ultra-high resolution with
narrow mass tolerance windows (±2 mDa); b) data-dependent MS/MS using HCD
activation on 20 selected precursor ions from full scan MS; and c) MRM analysis for six
targeted AZAs using CID MS/MS in the LIT mass analyser (Table 4.1).
The high quality accurate mass data for ions across the entire spectral range were acquired
by scanning at maximum resolution (100,000 FWHM). Although this increases the scan
time to 1.6 s in the Orbitrap XL, there is no effect on LIT MS data acquisition. High
resolution and high mass accuracy determinations are important for the analysis of AZAs
to achieve a high confidence in analyte identity, using both precursor and product ion
formulae confirmations, since standard toxins are not readily available. 7he only
compromise is that very fast chromatography is not possible as there would be insufficient
scan events for data collection across very narrow chromatographic peak intervals.

4.3.3 Evaluation of matrix effects
During LC-MS analysis, the response observed in electrospray ionisation can be affected
by factors other than analyte concentration and a variety of approaches have been proposed
to evaluate matrix effects. [276; 277] Two approaches were used in this study; post-column
infusion [278] of standard AZAl and standard addition [279] of AZAl. Post-column
infusion is useful to qualitatively indicate if there is ion suppression/enhancement in
electrospray ionization. [278] A standard solution of AZAl in methanol (0.3 pg/mL) was
infused into the chromatographic eluate of an extract from nontoxic mussel tissues and the
signal was monitored using both full-scan FTMS and CID MS/MS for 20 min. During the
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first minute of chromatography, the eluate was sent to waste and there was no significant
negative or positive response for AZAl after 2.5 min of chromatography. The monitored
signal for AZAl, using a mussel tissue extract injection, was stable and comparable to the
AZAl infusion experiment in which only water was injected. Figure 4.2 shows that there
were no significant matrix effects during this period of chromatography and especially
during the time period for monitored azaspiracids.

NL:3.22E7

1003

0 7’”’'*"'***"I
10
12
14
16
18
20

Time (min)

Figure 4.2. Matrix ion suppression/enhancement assessment: AZAl signal response using full-scan
MS with post-column infusion of AZAl (0.3 pg/mL) with LC water injection (blue line) and
injection of an extract from non-toxic mussel tissue (red line); the time interval where monitored
azaspiracids elute in LC is 3 - 12 min.

The standard addition method was also used to quantitatively assess matrix effects. In this
case the content of AZAl in a mussel (M edulis) tissue extract was determined using CID
MS/MS as 0.134 ± .006 pg/mL (n = 6) when quantified using external calibration of AZAl
solutions, prepared in methanol. For the standard addition experiments, this extract was
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spiked with five aliquots of AZAl, equivalent to the addition of 10 - 120 ng AZAl and
each solution was made up to 200 pL. The extrapolated standard addition plots (Figure 4.3)
were obtained from the analysis (n = 6) of the AZAl content of each solution using CID
MS/MS and full-scan FTMS and the amount of AZAl in the shellfish extract was
determined as 0.134 ± 0.012 pg/mL (CID MS/MS) and 0.132 ± 0.015 pg/mL (full-scan
FTMS). These experiments confirmed that matrix effects are probably not significant in
the analysis of AZAs using the described methodology.

ng

ng

Figure 4.3. Standard addition calibration graphs (n = 6) for the determination of AZAl in mussel
tissues; A) LC-MS (full-scan FTMS) and B) LC-MS/MS (LIT CID).
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4.3.4 LC-MS method performance and validation
The specificity of a full-scan MS is usually demonstrated by means of high mass accuracy
measurements. In the case of MS/MS scans, acquired using LIT MS or QqQ MS, the
discrimination between compounds with closely related structures is achieved by using
analyte specific selected reaction monitoring (SRM). Although a high mass resolution MS
instrument accommodates a less completely resolved chromatographic separation [117] the
current application is complicated by the presence of two sets of azaspiracid isomers
(AZA1/AZA6 and AZA4/AZA5). Therefore, each of the six azaspiracids were
chromatographically resolved to improve method specificity. The stability of the retention
times for each azaspiracid was also examined by analyzing a mussel (M edulis) tissue
extract, containing AZAl - AZA6, five times, over a three-day period. The relative
standard deviation (RSD %) values of the retention time data for all six azaspiracids were
<3.45%(n= 15).
An example of the full-scan MS data from a mussel extract at the retention time for AZAl
using LC-FTMS is shown in Figure 4.4. The AZAl concentration in this sample was just
above the limit of quantitation and the high mass accuracy data for the isotopic distribution
of AZAl are also shown. All four isotopic ions that were observed had accurate mass error
values < 0.6 ppm which demonstrates the importance of using high resolution for analyte
confirmation.
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Figure 4.4. A) LC/FTMS full-scan data for AZAl, m/z 842.50545 ([M+H]' theoretical value), in
an extract of mussel tissue. B) Isotopic peak resolution and accurate mass data for AZAl.

To assess the accuracy and precision of the high mass accuracy data using samples with
varying concentrations of the AZAs, a total of 39 mussel tissue extracts were analysed
using full-scan FTMS, at a resolution setting of 100,000 (FWHM), with the lock mass
option employed, as described in the Experimental Section. The [M+H]^ ions of AZAl,
AZA2 and AZA3 (Table 4.1), were extracted post-acquisition, using ± 2 mDa mass
tolerance windows and all precursor masses were within ± 0.4 ppm of their theoretical
mass values, even at concentration levels close to the LOD. Kellmann et aL, demonstrated
the importance of high resolution for the determination of isoproturon in horse feed. Using
a 2 ppm mass window and a resolving power of 10,000 FWHM, several scans across the
chromatographic peak contained significant mass assignment errors and reproducible
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quantitation was not achieved even with increased mass isolation windows (up to 25 ppm).
However, using a mass resolution of 100,000 FWHM, the correct mass assignments were
obtained for all scans across the chromatographic peak, with good peak shape and
consistent analyte response.

Figure 4.5. Accurate mass measurements for 3 toxins in shellfish tissue extracts.

4.3.5 Linearity, Limits of detection (LOD) and limits of quantitation (LOQ)
The linear range for AZAl was investigated by using a toxin-free mussel (M
galloprovincialis) tissue extract that was spiked with AZAl standards, at different
concentration levels. These spiked extracts were analysed daily six times over a 3-day
period and the curves were found to be linear in the concentration range 0.01-3.00 pg/mL
(equivalent to 0.005-1.5 pg/g shellfish tissues). The validation data are shown in Table
4.3, using both full-scan FTMS and LIT CID MS/MS both methods had good linearity and
the limits of quantitation (LOQs) were comparable.
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Table 4.3. Validation data for AZAl determination in mussel (M galloprovincialis) tissue extracts
Linear range
(pg/mL)

Equation of line

FTMS fullscan

0.010-3.0

Y=4.E+08X+L8.E+08

LITCID
MS/MS

0.0080-3.0

Y=5.E-f06X-2.9.E+04

Method

LOD

LOQ

(Fg/g)

(Pg/g)

0.9995

0.0031

0.010

0.9996

0.0021

0.0070

Correlation
coefficient (R^)

4.3.6 Accuracy and precision.
The accuracy of the method was assessed by measuring the difference between the mean
found value and the certified value of the CRM AZAl (1.237 pg/mL) and was carried out
in accordance with the European Commission Decision on the performance of analytical
methods. [280] Using full-scan FTMS, the found value was 1.275 pg AZAl/mL, RSD%
2.4 (n=6), and the accuracy was determined to be 103 % of trueness. When using LIT CID
MS/MS, the found value was 1.234 pg AZAl/mL, RSD% 1.9 (n = 6), resulting in 99.8%
of trueness. Method precision was assessed in terms of intra-day and inter-day
repeatability. Four eoncentration levels of AZAl were prepared by spiking blank shellfish
tissue extracts with AZAl standard to produce extracts containing AZAl (15-90 ng)/200
pL. Each sample was analysed (n = 6), the concentrations were calculated, and these steps
were repeated on two other days. Table 4.4 shows the mean AZAl concentration values
and the RSD% values that were obtained for the spiked samples. The full-scan FTMS and
LIT CID MS/MS analytical data were equivalent and demonstrated good repeatability. The
inter-day RSD% data (4.7 - 8.6 %) were higher than the intra-day RSD% data (1.8 - 4.4
%) but both data sets were acceptable for trace contaminant analysis.
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Table 4.4. Precision assessment data for AZAl determination in mussel (M
galloprovincialis) tissue extracts
Repeatability (Intra-day)
Repeatability (Inter-day)
AZAH
SD*’
RSD‘=(%)
AZAH
SD*’
RSD‘^(%)
(pg/mL)
n=6
n=6
(pg/mL)
n=6
n=6
FTMS full-scan
0.095
0.187

0.004

0.087
0.179

0.007

0.008

3.7
4.4

0.375
0.557

0.009
0.010

2.3
1.8

0.362

0.017
0.041

4.7

0.006
0.009

7.3
5.9
7.2

0.536

0.008

7.5
4.7
7.6

LIT CID MS/MS
0.089
0.168
0.338
0.523

0.003
0.007

3.5
4.1

0.008
0.011

2.3
2.1

0.081
0.158
0.316
0.490

0.023
0.042

8.6

‘ measured concentration, standard deviation, relative standard deviation

4.3.7 Application of full-scan MS for the determination of azaspiracids in mussels
Blue mussels (M edulis) were dissected into three parts, hepatopancreas (HP), gills and
remaining tissues (RT), and extracted for the determination of their azaspiracids content
using the developed LC-MS methods. Six azaspiracids (AZAl - AZA6) were found in
nearly all samples and Figure 4.6 shows typical ion chromatograms (full-scan FTMS) that
were obtained for a mussel tissue extract. These chromatograms were generated post
acquisition using four selected theoretical mass values with a mass tolerance window of ±
2 mDa. The isomeric pairs, AZA1/AZA6 and AZA4/AZA5 were chromatographically
resolved and were quantified using full-scan FTMS to allow a comparison with CID
MS/MS data. Part of the concentration data for azaspiracids in mussels are shown in Table
4.5 for illustration of the good correlation that was obtained.
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842 50538
.

Figure 4.6. LC-MS ion chromatograms of azaspiracids in an extract of mussel (M edulis) tissues,
obtained using full-scan FTMS at 100,000 FWHM resolution. The found masses and error values
are shown above each peak. The chromatograms were generated post-acquisition using four
selected theoretical mass values with a mass tolerance window of ± 2 mDa. The extracted ion
chromatogram relating to m/z 844 has been amplified by 10-fold.

Using a paired t-test for the complete data sets for all six azaspiracids, the |t^| values were
in the range, 0.47 - 1.59, and since jt^l < 2.31 [t(8,0.05)], demonstrating that there is no
significant difference, at 5% significance level, between the two sets of data. The current
European limit for azaspiracids in shellfish is 0.16 pg/g and only AZAl, AZA2 and AZA3
are included monitoring programs, but significant levels of AZA4, AZA5 and AZ6 were
also present mussel tissues (Table 4.5), which has implications for current food safety
regulations. [281]
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Table 4.5. Comparison of concentration data for six AZAs in mussels (M
edulis), determined using full-scan FTMS and LIT CID MS/MS
AZAl

AZA2

AZA3

AZA4

AZA5

AZA6

Pg/g

Pg/g

Pg/g

pg/g

pg/g

pg/g
0.040
0.919
0.034

FTMS Full scan
1 gills
1 HP"
1 RT^

0.044

0.034

0.070

0.035

0.033

0.989

2.443
0.092

0.458
0.022

0.410

0.047

0.456
0.022

2 gills
2 HP"
2 RT^

0.826

0.167

0.078

0.049

3.013

0.573

0.282

0.307
0.078

0.055
0.051
0.270
0.026

0.032

0.089
0.014

3 gills
3 HP"
3 RT^

0.597
0.063

0.025
<LOD
0.045

0.157
0.023

0.016
0.044
0.159
0.018

0.107
0.071

0.040
0.456
0.024
0.041

0.038
0.417
0.029
<LOD

0.035
0.938
0.039
<LOD

0.278
0.036

0.092
0.011

0.040
0.013
0.051

0.093
0.011
0.039

0.163
0.024

0.161
0.014

0.090
0.308
0.040

0.055
0.158
0.016

0.011
0.059

<LOD
0.089

LIT CID MS/MS
1 gills
1 HP"
1 RT^

0.039
1.099

2 gills
2 HP"
2 RT*’

0.053
0.827
3.077
0.312

3 gills

0.070

3 HP"
3 RT*’

0.606
0.070

0.021
0.466
0.021
0.168
0.586
0.067
0.042

0.075
2.504

0.086

0.050

0.287
0.028

0.310
0.044

0.162
0.013

®Hepatopancreaces, “remaining tissues

Since the MS data collected also included data-dependent HCD MS/MS scans using 20
pre-selected ions, other AZA analogues were detected in mussel samples. These analogues
had previously been observed using MS methods but have not so far been isolated for full
structural elucidation. Four compounds were detected at levels above the LOQ and were
quantified as AZAl equivalents. These included, AZAS (23-hydroxy-AZA 1; < 0.08 pg/g),
AZA9 (3-hydroxy-AZA6; < 0.08 pg/g), AZAl7 (22-carboxy-AZA3; < 0.04 pg/g) and
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AZA19 (22-carboxy-AZA6; < 0.04 |ig/g). Figure 4.7 shows the HCD product ion mass
spectrum that was obtained for protonated AZA9 to illustrate the quality of the high mass
accuracy data that was obtained for the major product ions which provides valuable
confirmation of analyte identity in the absence of a reference standard toxin.
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Figure 4.7. The FTMS HCD spectrum for AZA9, from fragmentation of the ion, m/z 858, [M+H]^.
The accurate masses for ions are shown with the error differences (ppm) from calculated values in
bold. The insert scheme shows the main fragmentation processes of the [M+H-H20]^ product ion.
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4.4 Conclusion
A hybrid MS instrument, the LTQ Orbitrap, was exploited to develop and validate a
methodology for the determination of azaspiraeids in shellfish using simultaneous targeted
and non-target LC-MS analysis. A high-resolution setting (100,000 FWHM) was used for
non-target analysis and azaspiraeids were determined post-aequisition from full-scan
FTMS Orbitrap data. Targeted analysis of six azaspiraeids was performed simultaneously
using CID MS/MS in a linear ion trap mass analyzer. The analytical data generated for
shellfish tissue samples showed a high degree of correlation between the two procedures,
with comparable LODs and LOQs. In addition to the analytical data, automatic generation
of FICD MS/MS produced high mass accuracy product ion spectra, over a wide m/z range,
which was valuable for analyte confirmation. The validated full-scan LC-MS method that
has been developed should be applicable to the determination of azaspiracid analogs for
which standards are not available. Work described in this chapter is published as a research
article. [118J
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CHAPTERS

Ultra High Resolution Full-Scan Mass
Spectrometry for the Study ofAzaspiracid
Biotransformation in Shellfish

5.1 Introduction
AZAl is usually the predominant toxin in shellfish but because of the higher toxicity of
AZA2 and AZA3 [241], the monitoring of all three toxins is required by international
regulation. [194] Although AZAs can accumulate in other bivalve shellfish, including
oysters, scallops, cockles and clams, we previously observed that the AZA toxin profiles in
these shellfish were much less complex than in mussels {Mytilus edulis) and only AZAl
and AZA2 have been identified in most shellfish species. [196] In addition to AZAl and
AZA2, AZA3 has also been detected in mussels Mytilus galloprovincialis from Spain
[186] and Portugal [204]. Thus, many AZA analogues are suspected bioconversion
products in mussels.
When AZAl was fed to blue mussels (M edulis), multiple reaction monitoring (MRM)
triple quadrupolc (QqQ) MS was used to determine the toxin profiles in mussel tissue
compartments and confirmed the hypothesis that the demethyl analogue, AZA3, was a
major bioconversion product of AZAl. The second most abundant bioconversion product
was identified as AZA 17, a carboxyl analogue of AZA3, which is probably a key
intermediate in the formation of AZA3. AZA 17 is with the probability 22-carboxy-AZA3
and a mechanism for its facile decarboxylation to form AZA3 was proposed. Also, two
pairs of isomeric hydroxyl analogues, AZA4/AZA5 and AZA7/AZA8, have been
confirmed as bioconversion products for the first time. [282]
Highly sensitive non-target MS methods are increasingly being applied to metabolomics
and drug metabolite studies as they offer greater scope for the detection of unknown or
unexpected metabolites. [125; 283] Since C-demethylation is such a rare xenobiotic
bioconversion process, the main objective of the study reported herein was to identify
bioconversion products and pathways by using ultra-high resolution full-scan MS to
determine the toxin profiles in the tissue compartments of mussels (M galloprovincialis)
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and Manila clams {Tapes philippinarum) that had been fed with pure AZAl. This study
confirms that MediteiTanean mussels, M galloprovincialis, use similar biotransformation
mechanisms to eliminate the azaspiracids as blue mussels, M. edulis. It also demonstrated
that AZAl does not undergo this biotransformation in Manila clams, T. Philippinarum.
Finally, a proposed in vivo deearboxylation observed in mussels, was also demonstrated in
vitro by heating isolated AZAl7 to form AZA3.

5.2 Experimental section

5.2.1 Materials
Toxic mussels {Mytilus edulis) collected from the northwest coast of Ireland and
azaspiracid (AZAl) was isolated using procedures that were previously developed.
Calibration studies were performed using a certified referenee standard AZAl, CRMAZAl (1.24 pg/mL; NRC, Halifax, Canada).
All solvents including acetone, ethyl acetate, HPLC grade water, methanol and acetonitrile
were purchased from Fisher Scientific (Dublin, Ireland). Trifluoroacetic acid (TFA) and
ammonium acetate (Sigma-Aldrich, Dublin, Ireland) were used as mobile phase modifiers.
Mediterranean mussels {Mytilus galloprovincialis) were obtained from south coast of
Sardinia, Italy and Manilla clams {Tapes philippinarum) from Burren, Co. Clare.
Mussels and clams were dissected into three tissue compartments, gills, hepatopancreas
(HP) and the remaining tissues (RT). Each tissue compartment (0.5-1.0 g) was
homogenized (Ultra Turrax, IKA, Germany) with acetone (4 mL) in a centrifuge tube (50
mL) for 1 min, followed by centrifugation at 704 g (3000 rpm) for 3 min. The supernatant
was transferred to a volumetric flask (10 mL), the extraction procedure was repeated.
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combined with the first extract and made up to 10 mL with acetone. An aliquot (3 mL) was
evaporated using nitrogen at 20 °C (TurboVap, Zymark, MA, USA). The remaining
residue was extracted using ethyl acetate (2x2 mL) and the combined extracts were
evaporated using nitrogen. The residue was reconstituted with acetonitrile (200 pL) using
sonication and vortex mixing and 5 pL of this solution were used for LC-MS analysis.

5.2.1.1 Shellfish acclimation and AZAl feeding experiments
Mediterranean

mussels

{Mytilus

galloprovincialis)

and

Manilla

clams

{Tapes

philippinarum) were acclimated in sea water tanks under environmentally controlled
conditions in the Environmental Research Institute (ERI), UCC for six and three months,
respectively. During this period, mussels were kept in two 100 L tanks and clams were
kept in one 100 L tank, all eontaining 60 L of seawater, maintained at 14 ± 0.5 C, with
constant aeration, under low light intensity exposure and fed with a shellfish diet
(described below). One fifth of the seawater volume was replaced every day.
For feeding experiments, 10 shellfish of each species were placed in two experimental
glass tanks (20 L), containing seawater (10 L) at 14 °C. Shellfish diet 1800 (a mixed diet of
Isochrysis, Pavlova Thalassiosira weissfloii Tetraselmis) was administered in accordance
with the supplier’s recommendations (Reed Mariculture Inc, Cambell, CA, USA). Pure
AZAl was administered (3 pg AZAl/day) over a 10 day period. Two shellfish from each
tank were removed after 2, 4, 6, 8 and 10 days and opened, rinsed in Milli-Q water and
weighed. The shellfish were dissected into three parts (digestive glands or hepatopancreas
(HP), gills and remaining tissues) and extraction procedure was carried out on each tissue
compartment. A complete seawater change was carried out every second day prior the
toxin administration.
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5.2.2 LC conditions
Chromatographic separations were carried out using an Accela LC system (Thermo
Scientific, Hemel Hemstead, UK), equipped with a Security Guard cartridge (Cis, 4.0 mm
X 2.0 mm, Phenomenex, Macclesfield, UK) with a reversed-phase analytical column (Luna
Ci8(2), 3|im, 150 X 2 mm; Phenomenex) maintained at 35 °C. The chromatographic
conditions were the same as used in chapter 4.

Table 5.1. m/z ratio of the parent and major fragment ions of 14
azaspiracids.
Toxin

fM+Ht

IM+H-H20t

lM+H-H20-A-nngt

AZAl

842.5

824.5

672.4

AZA2

856.5

838.5

672.4

AZA3

828.5

810.5

658.4

AZA4

844.5

826.5

658.4

AZA5

844.5

826.5

674.4

AZA6

842.5

824.5

658.4

AZA7

858.5

840.5

672.4

AZA8

858.5

840.5

688.4

AZA9

858.5

840.5

658.4

AZAIO

858.5

840.5

674.4

AZAll

872.5

854.5

672.4

AZA12

872.5

854.5

688.4

[M+H-H20-C02t

[M+H^20-A-ring-C02t

AZA17

872.5

810.5

658.4

AZA19

886.5

824.5

658.4

5.2.3 Mass spectrometry conditions
The LC system was connected to a hybrid linear ion trap MS-FT mass spectrometer (LTQ
Orbitrap XL, Thermo Scientific), with a heated electrospray interface (H-ESI), operating in
positive ionization mode. A validated method described in chapter 4 was used for analysis
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of azaspiracids in mussel and clam tissue extracts. Only modification in validated method
was in scan event c). CID MS/MS scans were acquired for precursor/product ion pairs of
14 AZAs (Table 5.1.) using the LIT MS.

5.3 Results and discussion
Liquid chromatography coupled to ultra high resolution hybrid mass spectrometry method,
validated for analysis of azaspiracids in mussel tissues, was applied to the determination of
azaspiracids in M galloprovincialis and T. philippinarum tissue compartments (gills,
hepatopancreas and remaining tissue). Good sensitivity, nanogram level, of full-scan MS
method for the determination of azaspiracids in complex shellfish extract was achieved by
operating the Orbitrap mass analyser at the highest resolving power setting, 100,000
FWHM.

5.3.1 Importance of resolving power for non-target analysis
Coupling LC to high resolution mass spectrometry (HRMS), providing high mass accuracy
acquisition, is a powerful tool for trace contaminant analysis. Hybrid linear ion-trap
Orbitrap MS delivers reliable detection and identification data for low concentration levels
of compounds in complex matrices based on high resolution accurate mass measurement of
precursor and product ions. The features, advantages, and limitations of LC coupled to
HRMS for quantitative target analysis with reference standards, suspects screening without
reference standards and non-target screening of unknowns was recently reviewed by
Krauss et al. [113] Target analyses are not suitable for the determination of novel
compounds, their degradation products and the products of bioconversion. For this purpose
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full-scan MS methods, acquiring data at sufficient resolution, are the only choice.
Moreover the archived data can be reanalysed for the presence of other compounds at any
time subsequent to acquisition. To obtain structural information, hybrid instillments offer
the possibility of data-dependent MS/MS acquisition, where MS/MS analysis is triggered
for a precursor ion detected in the full-scan. [115; 118] Employing an extensive clean-up
step prior to analysis limits the number of compounds that can be determined during one
analytical run. In order to avoid analyte losses, the sample preparation step should be
eliminated as much as possible. [119] Determination of trace concentration levels of
compounds in an extract containing most of the matrix can however be very challenging.
This is when the importance of ultra high resolving MS can be seen by the reduction of
interfering background ions and improvement in the sensitivity of measurements through
enhanced selectivity. The required mass resolution depends on the ratio of compound
concentration to the concentration of co-eluting interferants from the matrix. [122] and
very good mass accuracy (< 5 ppm) has been achieved for different types of mass
analysers, including TOP MS. [123; 284] Therefore, very accurate mass can be assigned to
a compound isolated chromatographically from isobaric components in a sample. For
example Figure 5.1 shows excellent mass accuracy for azaspiracid-17 {m/z 872.47963)
regardless mass resolution at which the data were acquired, despite the presence of a small
amount of azaspiracid-11 {m/z 872.51602) a co-eluting isobaric (A 0.036 mDa) azaspiracid.
Although the mass for AZA17 was determined only with a 1.0 ppm error using a 15,000
FWHM resolution setting, it was not possible to predict the presence of a co-eluting
compound in this spectrum. Mass measurements at a 15,000 FWHM resolution setting for
AZAll are not as accurate due to the higher concentration of AZA17, co-eluting with
AZAl 1, and more importantly due to a co-eluting interference, differing by approximately
62 mDa from AZAll. However, a 60,000 FWHM resolution setting was sufficient to
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resolve this interfering ion from the AZAll precursor ion, [M+H]^, and the mass was
assigned with an error of just 0.80 ppm which further was improved by resolving AZAl 1
from AZAl7 at a 100,000 FWHM resolution setting. It can be concluded, that the mass
resolving power required also depends on the chromatographic resolution of the
compounds of interest from isobaric interferants. Use of ultra high resolution for analysis
of trace concentration levels of analytes using full-scan MS enhances the confidence in
analyte identification.

A)
100

AZA17

872.47987
R=88043

B)
AZA11

100

872.47963
C47H70NO14

100k

872.51658
R=87031

872.51602

100k

C48H74NO13

0.27 ppm

0.64 ppm

50
A2A11
872.51656
R=87410

~.......

872.48007

50
A7A17 872.47908
^
R=94819

Coeluting interference
872.57812

R=87572
■-.o........
872.51672

Figure 5.1. Assignment of accurate mJz values for isobaric AZA analogues A) AZAl7 and B)

AZAl 1 in mussel (M edulis) tissue extract, acquired at different resolving power. Precursor ions
[M+H]^ of AZA 17 {m/z 872.47963) and AZAl 1 {m/z 872.52110) were extracted from full-scan,
using 2 mDa tolerance window.
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5.3.2 Distribution of azaspiracids in clams
In previous studies, a linear quadrupole ion-trap (LIT) mass analyser was used for
determination of AZAs in clams, Tapes phillipinarum from Ireland [196] and Mulinia
edulis from Chile [206]. Triple-quadrupole (QqQ) and hybrid quadrupole time-of-flight
(Q-TOF) mass analysers were used for the analyses of clams from Portugal, including
Venerupis senegalensis, Ruditapes decussates and razor clams, Solen marginatus. [204]
The results of these studies reported presence of AZAl and AZA2 in the whole flesh of
clams.
To determine the distribution of azaspiracids in the clam tissue compartments (gills, HP,
RT), they were extracted separately and analysed employing both mass analysers
incorporated in the LTQ Orbitrap MS. The precursor ions, [M+H] y for azaspiracids were
extracted from full-scan MS using narrow mass tolerance window (±2 mDa). Only AZAl
and AZA2 were detected in clams, which correlates with results observed previously. [ 196]
LIT MS, operating in MRM mode provided similar data. In addition to obtaining very
accurate m/z values for both azaspiracids from the fiill-scan MS data, the HCD MS/MS
spectra confirmed their structures by providing accurate m/z values for generated product
ions. The mass distribution in clam was gills (15%), HP (10%) and remaining tissue
(75%). The concentration levels of AZAl and AZA2 determined in the clam tissue
compartments are summarised in a Table 5.2., demonstrating that the gills and HP tissues
contained most of those toxins.
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Table 5.2. Concentration levels of azaspiracids distributed through the clam tissues.

Clam Tissue Compartment
Gills

Mean (N=10)
Range
Mean (N=10)

Hepatopancreas

Remaining Tissues

Range
Mean (N=10)
Range

AZAl

AZA2

(fig/g)
0.072

(fig/g)
0.034

0.045-0.13

0.026-0.048

0.050

0.020

0.023-0.091

0.0085-0.035

0.035

0.018

0.012-0.078

0.0039-0.041

5.3.3 First identification of azaspiracids in Italy
Analysis carried on the extracts from mussels M galloprovincialis (n = 10) showed small
amounts of AZAl in all tissue compartments. The highest concentration levels were found
in the hepatopancreas (0.047 pg/g), which were below the current regulatory limit 0.16
pg/g, but the significance of this observation is that this is first time that this group of
toxins has been identified in shellfish from Italy. Extracted ion chromatogram from fullscan FTMS for AZAl from hepatopancreas of mussel M galloprovincialis, generated by
using exact mass 842.5055 m/z with ±2 mDa tolerance window, is shown in an insert of
Figure 5.2. A spectrum of the extracted peak demonstrates a very good mass accuracy
obtained for AZAl in this sample. The MS/MS analysis monitoring the [M+H]^ / [M+FIH20]^ ion pair ( m/z 842 / 824) in LIT MS confirmed this finding.

99

100

200

300

400

500

600

700

800

900

m/z

Figure 5.2. Full-scan FTMS spectra for AZAl in hepatopancreas of mussel M galloprovincialis
extracted from full-scan using exact mass 842.5055 m/z with ±2 mDa tolerance window. The
extracted ion chromatogram for AZAl is shown in the insert.

5.3.4 Azaspiracid-1 feeding experiment conducted on clams Tapes philippinarum
Manila clams, kept in the laboratory conditions in order to eliminate the azaspiracid levels
from their tissues, were sampled weekly and analyzed to determine the concentration
levels of AZAs in three tissue compartments (gills, hepatopancreas, RT). It was found
however, that the content of AZAl and AZA2 remained on the same level during three
months and no other AZA analogues were identified in the tissues. To establish possible
biotransformation of AZAl, the study involving feeding standard AZAl to clams, was
carried out as described in the experimental section. The content of AZA2 in the clams
subjected to feeding study remained the same as in clams that were not fed the AZAl
standard. Figure 5.3 demonstrates the increase of AZAl toxin in clam’s tissue
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compartments after those were fed AZAl standard. As other azaspiracid analogues were
not detected in any of the analysed tissue compartments after distribution of AZAl
standard to clams, it seems that AZAl does not undergo a biotransformation in clams
Tapes philippinarum. This result correlates well with the observation, that Manilla clams
do not readily depurate the levels of AZAl and AZA2 from their tissues.

—AZA1 in control clams
— AZA1 FSG
- AZA1 FSin HP
— AZA1 FSinRT

Figure 5.3. Manila clams (n = 9) accumulate the distributed AZAl standard toxin mostly in
hepatopancreas.
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5.3.5 Biotransformation of azaspiracid-1 in mussels Mytilus galloprovincialis
Analysis of azaspiracids in mussels, M galloprovincialis, kept in seawater under
laboratory conditions for a period of six months, gave negative results. Since no
azaspiracid analogue was detectable, these shellfish were ideal performing the feeding
experiment, involving the administration of AZAl to mussels, M galloprovincialis. This
feeding study was performed as described in an experimental section. Every two days after
the start of the AZAl feeding, two mussels were removed for analysis of azaspiracids. The
results obtained for the three tissue compartments revealed that AZAl undergoes a similar
biotransformation processes in M galloprovincialis as in blue mussels, M edulis. The bar
chart (Figure 5.4) shows the mean concentration levels (n = 2) of azaspiracids in three
tissue compartments following the administration of AZAl standard and sampled every
two days for analysis.

2.5 r'

TO
TO

mussel tissue compartment

Figure 5.4. Mean concentration (n = 2) levels of azaspiracids in the mussel tissues after each two

days of administration of AZAl standard into mussels M galloprovincialis.
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AZA17 (22-carboxy-AZA3) was the predominant toxin in each tissue compartment. The
most significant finding was that even though this toxin has never previously been reported
in this shellfish species. Also, significant levels of AZA3 were also present in ail samples.
This change was apparently caused by hydroxylation and oxidation of methyl group at C22
of AZAl to form a less toxic and water soluble carboxy-analogue AZA17, which
subsequently undergoes an enzymatic decarboxylation to form AZA3. [282] The
mechanism for the biotransformation of AZAl to AZA3 that involves oxidation and
decarboxylation has been proposed (Figure 5.5).

Figure 5.5. The mechanism for the biotransformation of AZAl to AZA3. [282]
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Similar to the study conducted on M. edulis, other azaspiracids that were identified
included the 23-hydroxy analogue of AZAl (AZA8) and the 3-hydroxy and 23-hydroxy
analogues of AZA3 (AZA4, AZA5, respectively). AZA4/AZA5 were found at
concentration levels less than 4 % of total azaspiracids and even lower concentration levels
(< 0.6 %) of AZA8 was observed. This is the first identification of carboxyl and hydroxyl
analogues of AZAl in this mussel species. Full toxin profile data are presented in Table
5.3. The most affected tissue, containing all identified analogues was the hepatopancreas.
The example of the extracted ion chromatograms of AZAs in the hepatopancreas of
mussel, M ^alloprovincialis, is shown in Figure 5.6. An important observation from this
study was that the combined levels of metabolites are consistently much higher compared
to the content of the originally administered AZAl standard. This demonstrates rapid
biotransformation and migration of AZA metabolites.

Table

5.3.

Concentration

levels

of

azaspiracids

distributed

through

the

mussel

M

galloprovincialis tissues.
AZAl

AZA3

AZA 17

AZA4

AZAS

AZAS

Mean (N=9)

(I4g/g)
0.19

(lig/g)
0.22

(lig/g)
0.70

(l^g/g)
ND

(Pg/g)
ND

(|ig/g)
ND

Range

0.0- 1.2

0.0 - 0.54

0.01 - 1.7

Mean (N=9)

0.25

0.12

0.39

0.04

0.06

0.02

Range

0.04 - 0.48

0.01 -0.38

0.03 - 1.6

0.0-0.21

0.0-0.17

0.0 - 0.04

Mean (N=9)

0.01

0.035

0.10

ND

0.007

ND

Range

0.0 - 0.02

0.0 - 0.09

0.02 - 0.30

Mussel Tissue
Compartment
Gills

HP“

Remaining
Tissues

0.0-01

“Hepatopancreas
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Figure 5.6. Full-scan FTMS extracted ion chromatograms for [M+H]^ of azaspiracids in
hepatopancreas of mussel M galloprovincialis after administration of AZAl standard obtained
using accurate theoretical mass with ±2 mDa tolerance window.

5.3.6 MS/MS HCD for structural confirmation of metabolites
Data-dependent MS/MS HCD spectra were generated for AZAl7 and AZA3 formed in
mussels, M galloprovincialis, by biotransformation of administered AZAl standard.
Fragments formed in the HCD collision cell were analysed in the Orbitrap mass analyser
and therefore very accurate m/z values were obtained for all product ions (Figure 5.7). The
HCD product ion spectra were generated by the fragmentation of the [M+H-H20-C02)]^
ion and one of the fragments, m/z 702, was formed by the A-ring cleavage from the [M+HH20)]^. The neutral water loss, followed by a decarboxylation, is the most facile process in
AZAl7 fragmentation. Thus, the HCD MS/MS spectra for AZAl7 and AZA3 are very
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similar because the [M+H-H20-C02)]^ ion formed in AZA17 fragmentation is identical to
the

[M+H-H20)]^

ion in AZA3

fragmentation and differ only

in this facile

decarboxylation.
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Figure 5.7. HCD MS/MS spectrum for AZA17 in mussel M galloprovincialis with
calculated errors (ppm) for the product ions m/z values.

5.3.7 In vitro conversion of AZA17 to AZA3
AZA 17 was isolated from mussel tissues and heated at 80 °C in acetonitrile/water (50/50;
v/v) for 15 min in a sealed vial. Analysis of this solution using the LTQ Orbitrap MS, with
full-scan MS and HCD MS/MS, showed a 97 % decrease in AZA17 concentration.
Comparison of chromatographic retention times with an authentic standard showed that
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AZA3 was the main product (54 %), together with an AZA3 isomer (43 %), which had
lower retention time (Figure 5.8).

Figure 5.8. Full-scan FTMS extracted ion chromatogram demonstrating the formation of AZA3
and an unidentified isomer from AZA17 by heating.

The identification of AZA3 was confirmed using high resolution HCD MS (Figure 5.9 A).
The heat lability of AZA17 was observed in a previous study when mussel tissue
homogenates, containing multiple azaspiracids analogues, were heated to 80 °C. The
AZA17 content declined with an observed increase in AZA3 that was much greater than
100%. [285]
The comparison of HCD MS/MS spectra of AZA3 and its isomer, with lower retention
tine, showed, that the main differences in these spectra were the product ions formed by
A-ring cleavage which were not observed in the spectra of the AZA3 isomer (Figure 5.9).
A possible explanation is that the A-ring has opened during the heating of AZA17 at 80
°C.
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Figure 5.8. HCD MS/MS spectra of A) AZA3 and B) its isomer, both identified in the fraction of
isolated AZA17 subjected to heat (80 °C).

108

5.4 Conclusion
Current EU regulations relate only to the determination of AZAl - AZA3 in uncooked
mussels. However, the shellfish is usually consumed after cooking, which has an effect on
the profile of azaspiracids in the shellfish tissue. While mussels convert toxic AZAl
mostly to less toxic and water soluble AZAl7, by applying the heat AZAl7 undergo
decarboxylation to AZA3, which is even more toxic then AZAl. Therefore the mussels
become more toxic by cooking. Recently, several cases of human intoxications that
occurred in France and USA were caused by cooked mussels cultured in Bantry Bay, Co.
Cork. Mussels from this area are subjected to monitoring program using LC-MS/MS
methods for marine toxin analysis. Using this method, mussels from Bantry Bay were
qualified as safe for consumption prior the intoxication events, because the level of
combined AZAl - AZA3 concentration was below the regulatory limit. However, the
levels of AZAl7 in these mussels were not determined, which means that the content of
AZA3 in cooked mussels couldn’t be predicted. For this reason the revision of regulations
is urgently required to limit the potential for human intoxications from consumption of
cooked mussels.
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CHAPTER 6

Ultra High Resolution Full-scan FTMSfor
Metabolomic Studies: Identification of
Novel Azaspiracids in Scallops

AZA analogues have been identified in mussels {Mytilus edulis). [231] Although AZA3
have been found in mussels (Mytilus galloprovinciallis) as well [204], none of the AZA
biotranformation products has been detected in the other bivalve shellfish.
Scallops however have not become exclusively azaspiracid vectors in the food chain.
Among the other phycotoxin groups accumulating in shellfish, pectenotoxins (PTXs) and
yessotoxins (YTXs) derive their names from the scallop Patinopecten yessoensis, cultured
in Japan, from which they were first isolated. [66; 288] Yessotoxin (YTX), is produced by
Protoceratium reticulatum and Lingulodinium polyedrum. [289; 290] The hydroxylanalogue, 45-hydroxyyessotoxin (45-hydroxyYTX), is its metabolite in shellfish. [291;
292] Pectenotoxin-2 (PTX2) is produced by Dinophysis spp. but other pectenotoxin
analogues are metabolites of PTX2 in bivalves [293; 294; 295; 296] Pectenotoxin-6
(PTX6), carboxy-PTX2, has been shown to be a metabolite and is often predominant in
scallops, P. yessoensis. [226] Figure 6.1 shows the biotransformation scheme of
pectenotoxin-2 (PTX2) to PTX6 in P. yessoyensis. The oxidation of PTX2 at the methyl
group at C18 results in decreased toxicity in mouse bioassays. However, the same toxin is
converted to pectenotoxin-2 seco acid (PTX2SA), when undergoing rapid enzymatic
hydrolysis in mussels. [295; 296] Similarly, DTXl is mostly converted to DTX3 (3-acylDTXl compounds) in scallops but the free toxin predominates in mussels. [297] Therefore,
different shellfish species seem to bioconvert accumulated phycotoxins using different
mechanisms.

Ill

Figure 6.1. Biotransformation scheme of pectenotoxin-2 (PTX2) to PTX6 in Japanese
scallop (Patinopectin yessoyensis), involving hydroxylation and oxidation of a methyl
substituent to carboxylic acid.

AZA metabolites have not been detected in scallops probably due to the fact that the
screening of samples has been limited to those AZAs metabolites that have been
previously detected in mussels. The methods used so far for the determination of AZAs in
scallops Pec ten maximus, Argopecten purpuratus and Aequipecten opercularis have
employed quadrupole ion-trap (QIT) [186; 187; 196] and triple-quadrupole (QqQ) [207;
298; 299] mass analysers.
Although those methods perform reliably in the analysis of targeted compounds, providing
high sensitivity and specificity, they are not suitable for monitoring of unexpected
metabolites and degradation products. Moreover, the assumption proposed by Rehmann et
al. that all azaspiracid analogues can be detected using a transition from their precursor ion
[M+H]^ to product ion at m/z = 362, which is believed to be common for all AZA
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analogues, is incorrect, as will be demonstrated in this chapter. Such an approach would
fail do detect two major AZA analogues in scallops, P. maximus, as demonstrated in this
chapter.
Non-target full-scan MS methods have been successfully employed in numerous
applications for identification of metabolites of various compounds, as reviewed in chapter
2 of this thesis, and this approach was chosen in this project for the examination of extracts
from various shellfish species for presence of azaspiracids. Ultra high-resolution full-scan
MS complemented with higher collisionally induced dissociation (HCD) MS/MS data
acquisition to produce informative product ion spectra for analytes targeted in the fullscan, previously validated for determination of azaspiracids in mussels, was successfully
applied for the identification of new analogues of AZAl and AZA2 in scallops P.
maximus. Based on the source, the carboxy-analogue of AZAl with a nominal mass of 872
m/z was named azamaxl and is shown to be an isomer of azaspiracid-17 and the carboxyanalogue of AZA2 with a nominal mass of 886 m/z (an isomer of azaspiracid-19) was
given a name azamax2.

6.2 Experimental section

6.2.1 Materials
King scallops {P. maximus) naturally contaminated with azaspiracids, were obtained from
various locations in Ireland: i) Ballycotton, Co. Cork, ii) Burren, Co. Clare, iii) Valentia
Island, Co. Kerry, iv) Lough Foyle, Co. Donegal. Each scallop was dissected into four
tissue compartments, gills, hepatopancreas (HP), gonad and adductor muscle, and a portion
of each tissue compartment (1 - 3 g) was homogenised (Ultra Turrax, IKA, Germany) with
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acetone (4 mL) in a centrifuge tube (50 mL) for 1 min, followed by centrifugation at 700 g
(3000 rpm) for 3 min. The supernatant was transferred to a volumetric flask (10 mL), the
extraction procedure was repeated, combined with the first extract and made up to 10 mL
with acetone. An aliquot (3 mL) was evaporated using nitrogen at 20 °C (TurboVap,
Zymark, MA, USA). The remaining residue was extracted using ethyl acetate (2x2 mL)
and the combined extracts were evaporated using nitrogen and reconstituted using
methanol (600 pL) prior to LC-MS analysis.
Azaspiracid standards were prepared by isolation from contaminated mussel (M. edulis)
tissues using multiple chromatographic separation procedures as described previously.
[182; 271]

hepatopancreas
adductor muscle

gonad

mantle

Figure 6.2. Photograph of scallop (Pecten maximus) organs

All solvents including acetone, ethyl acetate, HPLC grade water, methanol and acetonitrile
were purchased from Labscan (Dublin, Ireland). Trifluoroacetic acid (TFA) and
ammonium acetate (Sigma-Aldrich, Dublin, Ireland) were used as mobile phase modifiers.
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6.2.2 LC conditions
Chromatographic separations were carried out using an Accela LC system (Thermo
Scientific, Hemel Hemstead, UK), equipped with a Security Guard cartridge (Cig, 4.0 mm
X 2.0 mm, Phenomenex, Macclesfield, UK) with a reversed-phase analytical column (Luna
Cl8(2), 3pm, 150 X 2 mm; Phenomenex) maintained at 35 °C. The chromatographic
conditions were the same as used in chapter 4.

Table 6.1. m/z ratio of the parent and major fragment ions of 14
azaspiracids.
Toxin

fM+HJ^

fM+H-H20/^

fM+H-H20-A-ringjr

AZAl

842.5

824.5

672.4

AZA2

856.5

838.5

672.4

AZA5

828.5

810.5

658.4

AZA4

844.5

826.5

658.4

AZA5

844.5

826.5

674.4

AZA6

842.5

824.5

658.4

AZAl

858.5

840.5

672.4

AZAS

858.5

840.5

688.4

AZA9

858.5

840.5

658.4

AZAIO

858.5

840.5

674A

AZAll

872.5

854.5

672.4

AZA12

872.5

854.5

688.4

IM+H-H20-C02t

[M+H-H20-A-nng-C02t

AZAll

872.5

810.5

658.4

AZA19

886.5

824.5

658.4

6.2.3 Mass spectrometry conditions
The LC system was connected to a hybrid LIT MS-FT mass spectrometer (LTQ Orbitrap
XL, Thermo Scientific), with a heated electrospray interface (H-ESI), operating in positive
ionisation mode. The validated method described in chapter 4 was used for analysis of
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azaspiracids in scallop tissue extracts. The only modification of the validated method was
in scan event c) where CID MS/MS scans were acquired for precursor/product ion pairs of
14 AZAs (Table 6.1) using the LIT MS.

6.3 Results and discussion
Recent studies identified AZA17 (carboxy-22-desmethyl-AZAl) and AZA19 (carboxy-22desmethyl-AZA2) to be the main products of enzymatic oxidation of AZAl and AZA2
respectively in mussels. [282]
Given that similar biotransformation mechanism, involving hydroxylation and oxidation of
a methyl substituent to carboxylic acid, was observed in Japanese scallop {Patinopectin
yessoyensis) resulting in the formation of carboxy-PTX2, it was possible, that the richly
methylated structures of AZAl and AZA2 can undergo similar oxidations in scallops, P.
maximus.
In all previous studies, involving King scallops {P. maximus). Queen scallops {Aquepectin
opercularis) and Chilean scallops (Argopectenpurpuratus), only AZAl, AZAl and a trace
level of AZA3 were determined, predominantly in digestive glands. [186; 187; 196; 298;
299] A recent study of AZAs in Chillean scallops [207] showed that the predominant toxin
was AZA2, found predominantly in hepatopancreas and only low levels of AZAl were
observed. However, toxin profiles reported to-date have been obtained using target MS
methodologies.
To establish whether or not AZAl and AZA2 undergo oxidative biotransformation in
scallops, to form carboxylate metabolites, a previously validated method for the ultra high
resolution full-scan MS determination of AZAs in mussels was employed. The main
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advantage of a non-target full-scan approach to shellfish analysis is that the acquired data
can be archived and examined for a presence of azaspiracid analogues at any time
following data acquisition. Ultra high resolution (100,000 FWHM) and accurate mass
measurements, using narrow mass tolerance windows (± 2 mDa), help resolve and identify
analytes from background matrix ions with increased sensitivity due mainly to the
reduction in background signal

6.3.1 Full-scan FTMS

The Full-scan FTMS spectra of scallop {P. maximus) extracts were acquired at a 100,000
FWHM resolution setting (Figure 6.3). The post-acquisition examination of the total ion
count (TIC) full-scan m/z spectra revealed the presence of AZAl, AZA2, and another two
AZAs analogues, with m/z corresponding to [M+H]^ of AZAl 7 and AZAl 9. The [M+H]^
ions for all four AZAs were determined with very good mass accuracy, within 1 ppm
(Figure 6.3.B). This result wouldn’t be surprising, since AZAl7 and AZAl9 have been
detected in mussels. However, the extracted ion chromatograms from full-scan mass
spectra using m/z values of 872.47963 ± 0.002 and 886.49528 ± 0.002, corresponding to
precursor ion [M+H]^ of AZAl7 and AZAl9 respectively, differed from those usually
obtained from mussel extract analysis. The chromatographic retention time for [M+H]^ m/z
872 was 3.25 min. and for [M+H]^ of m/z 886 was 3.72 min. These retention times were
much lower than those of AZAl7 (6.50 min) and AZAl9 (7.82 min) (Figure 6.4). It was
concluded that the other two detected analogues, with the m/z values equal to those of
AZAl7 and AZAl9, were isomers and were named azamax-1 (AZAMl) and azamax-2
(AZAM2), based on the source shellfish P. maximus.
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6.3.2 CID MS/MS in LIT MS

Using CID MS/MS in the LIT mass analyser, the SRMs of 14 targeted azaspiracids
resulted in positive results only for AZAl and AZA2. The most facile fragmentation
reaction for AZAl7 and AZAl9 undergoing CID is a water loss followed by the loss of
CO2 from precursor ions, corresponding to precursor/product ion pairs m/z = 872.5—>810.5
(AZAl7) and m/z - 886.5—>-824.5 (AZAl9). The absence of peaks monitoring these
reactions indicated that isomers, of AZAMl and AZAM2, probably do not undergo facile
decarboxylation.
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A)

FTMS + p ESI Full ms [50.00-1000.00]

NL;4.66E5

400.34217

FTMS + p ESI Full ms [50 00-1000.00]

NL:2.43E4

826.53849

AZAl
-0.05 ppm
842.50541

831.45189
AZA17?
-0.03 ppm
872.47961

894,52139

AZA2
- 0.31 ppm
856.52083
858^2708

844.51210
836.73041

.... ......
810

820

830

840

AZA19?
874.48694

854.46901
848.52193

/

/

869.4772
862.90731

0.58 ppm

886.49580
891.2397:
'9 I
878J5158 ^

899.47685
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m/z

Figure 6.3. A) LC-FTMS full-scan data from scallop HP extract. B) Window of AZAs m/z region
showing [M+H]^ , corresponding to AZAl, AZAl, and another two AZAs, which were identified
to be an isomers of AZAl 7 and AZAl9. Errors from theoretical values of AZAl, AZA2, AZAl7
and AZAl9 are calculated as ppm.
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P. maximus
AZAM1
■0.31 ppm

Figure 6.4. LC-FTMS full scan extracted ion chromatograms with tolerance windows

± 0.002

mDa. AZA17 (RT = 6.50 min) and AZA19 (RT = 7.82 min) were determined in a tissue extract of
mussel M. edulis and AZAM I (RT = 3.25 min) and AZAM2 (RT = 3.72 min) were determined in a
tissue extract of scallop P. maximus.

6.3.3 Fragmentation studies of azaspiracids using HCD MS/MS
The HCD MS/MS spectra for AZAMl and AZAM2, acquired as data dependent scan
using relative collision energy (RCE) of 48%, enabled elucidation of fragmentation
pathways and therefore the structures of AZAMl and AZAM2. Since HCD effectively
eliminates the low mass cut-off, a drawback typical of most ion-trap mass analyzers, the
fragmentation spectra (Figure 6.5 and 6.7) are rich in fragment ions of low m/z values.
High mass accuracy data were acquired for all precursor and product ions. The difference
between the theoretical and observed m/z values, calculated as A mu, was consistent for all
fragment ions, with relative standard deviation (RSD) of 50 - 60 %. Such a high accuracy
in the determination of the m/z values enhances the fragment ions assignment.
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Figure 6.5. The FTMS HCD MS/MS spectrum for AZAMl, from fragmentation of the ion, m/z
872, [M+H] '. The insert scheme shows the main fragmentation processes of the [M+H-H20]^
product ion.
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Figure 6.6. The FTMS HCD spectrum for AZA17, from fragmentation of the ion, m/z 872,
[M+H]"^. The insert scheme shows the [M+H-H20]^ product ion.
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Similarly, like in the previously obtained fragmentation spectra, product ions are formed as
a result of the charge-remote fragmentation of the azaspiracid skeleton with a strong
tendency for charge to remain on the nitrogen during fragmentation. HCD MS/MS spectra
for [M+H]^ of AZAMl and AZAM2 showed seven characteristic backbone fragmentations
of the polyether skeleton of azaspiracids, in addition to neutral losses of water molecules
from the precursor and product ions (Figure 6.5 and 6.7). The product ion [M+H-H20]^ is
formed due to a facile water loss that occurs at the geminal diol (C20-21) [228], forming
an epoxide as shown in the insert in Figure 6.5 and 6.7.
The two azaspiracids, AZAMl and AZAM2, differ from one another by methylation at C8
(A-ring) (Figure 6.9). Thus they produce different precursor ions and neutral water losses
from [M+FI]^ under HCD. The product ions formed by subsequent cleavages, commencing
on A-ring, a facile retro-Diels-Alder fragmentation, are common for both AZAMl and
AZAM2. The main difference in HCD spectra of AZAMl and AZAM2 compared to their
isomers AZA17 and AZA19, respectively, is the decarboxylation, that occurs on C22 of
AZA17 and AZA19 structure (Figure 6.6 and 6.8). The subsequent cleavages of the
AZA17 and AZA19 backbone occur after this decarboxylation, which give rise to
formation of product ions very different from those of AZAMl and AZAM2.
However, examination of AZAM 1 and AZAM2 HCD spectra in lower m/z region revealed
that product ions resulting from G-ring fragmentation have m/z value of 168, which is the
same as observed in HCD and CID spectra of all other azaspiracid analogues, which shows
that the H/I rings are identical.
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Figure 6.7. The FTMS HCD spectrum for AZAM2, from fragmentation of the ion, m/z 886,
[M+H] \ The insert scheme shows the main fragmentation processes of the [M+H-H2O] ' product
ion.

m/i

Figure 6.8. The FTMS FICD spectrum for AZA19, from fragmentation of the ion, m/z 886,
[M+H]^, The insert scheme shows the [M+H-H20]^ product ion.
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CH3
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Figure 6.9. General structure of azaspiracids showing designation of substituents for AZAl 7 and
AZA19, and their isomers, AZAMl and AZAM2.

The C27-C28 cleavage results in formation of product ions of m/z 310 for AZAMl and
AZAM2 and m/z of 280 for AZAl7 and AZAl9. The difference of 30 Da for the product
ions formed by C27-C28 cleavage of AZAMl and AZAM2 is a strong indication, that
while there is a methyl substituent at C30 in structure of AZAl 7 and AZAl9, this methyl
is carboxylated in structure of AZAMl and AZAM2. The fragmentation of the H-ring, as
well as the G-ring cleavage, produced ions of m/z 126 that is common for all azaspiracid
analogues. Figure 6.10 provides an overview of the fragmentation processes, observed in
HCD MS/MS spectra for AZAMl, AZAM2, AZAl7 and AZAl9, together with observed
m/z values for main product ions and calculated errors from the theoretical values (ppm
error). It has been suggested, in previous studies, that the product ions formed by E-ring
cleavage of azaspiracids could be used for screening shellfish samples for azaspiracids,
since this ion, m/z 362, was observed in the CID spectra of all known AZA analogues.
[231; 265; 268]
Such an approach would fail to detect the two new carboxy-azaspiracids in scallops and the
present study dramatically demonstrates the importance of high resolution full-scan MS.
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6.3.4 Distribution of azaspiracids in scallops {Pecten maximus)
Scallops, (n = 15) from four different locations, were dissected into four tissue
compartments, gills (9%), hepatopancreas (9%), gonad (15%) and adductor muscle(67%)
and separately extracted for the determination of their azaspiracid content using previously
developed and validated LC-MS methods. Four azaspiracids (AZAl, AZA2, AZAMl and
AZAM2) were found in nearly all HP extracts and Figure 6.11. shows typical ion
chromatograms (full-scan FTMS) that were obtained for a scallop tissue extract. These
chromatograms were generated post-acquisition using four selected theoretical mass values
with a mass tolerance window of ± 2 mDa.

842.50540

-0.06 ppm
872.47953

AZA1

Figure 6.11. LC-MS ion chromatograms of azaspiracids in a HP extract of scallop {P. maximus),
harvested in Ballycotton Co.Cork, obtained using full-scan FTMS at 100,000 FWHM resolution.
The found masses and error values are shown above each peak. The chromatograms were
generated post-acquisition using four selected theoretical mass values with a mass tolerance
window of ± 2 mDa.
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The levels of azaspiracids varied greatly in scallops harvested in different locations (Figure
6.12, Table 6.2) and variations were also observed between scallops harvested in one
location. AZAMl and AZAM2 were found to be prevalent in most of the gills and gonad
extracts. The average total toxin content in the digestive gland was 82%, which correlates
with data previously reported. [187] The average AZA content in the remaining tissue were
gills (10%), gonad (8%) and adductor muscle (1%). However, the most significant result
from this study of scallops was that the new azaspiracid, AZAMl, was found in all
samples at levels similar to AZAl.

Scallops from Burren, Co.Clare

OB
C

Gills
I AZAl

Scallops from Lough Foyle, Co.Donegal

■ AZA2

■ AZAM 1

■ AZAM2

Scallops from Valentia, Co.Kerry

Gills
Gonad
■ AZAMl

Gonad

I AZAl

IAZA2

Gonad
AZAMl

AM
■AZAM2

Figure 6.12. Mean concentrations of azaspiracids determined in four scallop’s compartments.
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Table 6.2. Mean concentrations of azaspiracids determined in scallops P. maximus from four locations
in Ireland.
AZA2

range

AZAM2

range

ng/g

ng/g

145-238

26.4

22.8-33.4

21.8

20.3-22.4

13.3

12.5-16.3

15.6

11.6-18.0

9.9

7.1-13.5

5.8

5.1-7.3

<LOD

azai

range

ng/g

ng/g

HP“

235

173-340

116

83.4-180

185

Gills

11.8

11.5-13.4

10.1

9.5-11.4

Gonad

12.2

11.0-15.3

9.9

7.2-13.1

am‘’

6.6

6.1-9.0

<LOD

azami

range

ng/g
ng/g
ng/g
Scallops from Ballycotton, Co.Cork

Scallops from Burren, Co. Clare
HP*’

22.8

16.4-33.3

8.7

4.4-16.1

51.6

9.1-14.5

10.8

4.5-23.1

Gills

7.5

LOD-7.5

7.3

LOD-7.3

8.1

LOD-8.1

8.7

LOD-8.7

Gonad

6.8

LOD-6.8

<LOD

12

LOD-12

6.5

LOD-6.5

AM"

<LOD

<LOD

<LOD

<LOD

Scallops from Lough Foyle, Co. Donegal
<LOD

37.1

<LOD

<LOD

<LOD

Gonad

<LOD

< LOD

11.8

am"

< LOD

< LOD

<LOD

HP®

44.8

Gills

21.1-57.4

21.7-56.0

<LOD
<LOD

LOD-12.4

<LOD
<LOD

Scallops from Valentia, Co.Kerry
HP®

26.1

18.3-37.0

5

4.0-6.3

21A

21.7-38.1

11.4

7.1-14.5

Gills

5.9

4.6-8.2

4.8

LOD-5.2

10.2

8.3-14.1

7.3

6.6-9.3

Gonad

4.8

4.2-5.5

3.6

LOD-4.1

5.2

5.0-6.2

4.6

4.0-5.4

am"

< LOD

3.1

LOD-3.1

<LOD

<LOD

hepatopancreas; adductor muscle

The highest concentration levels of azaspiracids were found in fresh scallops harvested in
Ballycotton, Co.Cork, which were purchased in English market, Cork, in April 2010. The
mean content of 8.3 pg of total azaspiracids per scallop was determined and the Figure
6.13. demonstrates the distribution of the total azaspiracids content in hepatopancreas
(HP), gills, gonad and adductor muscle (AM).
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Total AZAs 8.28 |ug/scallop

Gonad
1.16 |Ug

AM
1^8

Gills, 0.63 pg

Figure 6.13. Distribution of AZAs in scallops from Ballycotton, Co.Cork. On average 8.28 pg of
total AZAs was found per scallop with 5.88 pg of total AZAs (71%) accumulated in
hepatopancreas.

6.4 Conclusion
Scallops, Pecten maximus, a popular food in many cultures, were subjected to a study to
identify potential biotransformation produet of AZAl and AZA2 in this shellfish species.
A method, previously validated for determination of AZAs in mussels, consisting of three
scan events employing both mass analyzers in LTQ Orbitrap MS, was applied to achieve
this purpose. 7'he non-target approach enabled the detection of azaspiracid analogues that
have not been previously reported in either shellfish or phytoplankton. The names assigned
to these analogues were derived from their origin, P. maximus. Thus the metabolites of
AZAl and AZA2 are azamax-1 (AZAMl) and azamax-2 (AZAM2), respectively. Of
particular importance were the data-dependent HCD MS/MS scans, which generated
product ion spectra, with very high mass accuracy, for AZAl, AZA2 and two new AZA
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analogues, after a selection of their precursor ions from full-scan FTMS. The product ion
spectra for AZAMl and AZAM2 were characteristic of charge remote fragmentation of
azaspiracid backbone, with charge remaining on the nitrogen in the I-ring system. The
product ions typical of cleavages of the azaspiracid structure enabled structural elucidation
of AZAMl and AZAM2. The diagnostic product ions formed in the low m/z region
allowed for assignment of carboxy- substituent to the carbon C30 in the F-ring system in
both AZAMl and AZAM2 structures. AZAMl and AZAM2 were found to be highly
abundant in scallop tissues, particularly in the digestive gland and their relative
concentrations correlated with the relative concentration levels of AZAl and AZA2.
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CHAPTER 7

Nanoelectrospray Ultra High Resolution
Hybrid Mass Spectrometry: Direct
Analysis ofAzaspiracids in Shellfish

7.1 Introduction
Analysis of phycotoxins in the shellfish tissue is mandatory in order to determine the safety
of different shellfish species for consumption. The economic motives of the shellfish
industry, the freshness of shellfish reaching the consumer, the characteristics of those
toxins as natural products and the lack of predictability of their occurrence, requires that
methods used for the detection of these compounds need to be efficient and rapid. [300]
Azaspiracids were discovered following a human intoxication event in 1995 in the
Netherlands. [181] To-date, many more azaspiracid shellfish poisoning incidents have been
recorded, mostly in Europe. The toxicological studies involving azaspiracid, in
experiments performed in vivo and in vitro, have indicated their high potency to harm
human health. [246]
Azaspiracids undergo biotransformations in shellfish during digestion and assimilation,
and the increased complexity of the toxin profile due to naturally produced analogues and
their metabolites makes their quantification even more challenging. [231]
Initially, a mouse bioassay (MBA) was used as the detection method for azaspiracids in
monitoring programmes in Europe. It was shown that the MBA can detect AZAs at the
current regulatory limit of 160 pg/kg, although this assay cannot reliably detect any
concentration below this level. Moreover the observation time (24 h) makes this assay too
slow and inaccurate for quantitation as one must have complete observation every hour
over the 24 h period to be accurate. Therefore, since 2001 two tests have been used in
parallel: the MBA and LC-MS/MS for monitoring biotoxins in shellfish production areas
in Ireland. [260]
The sensitivity, specificity and speed inherent in LC-MS/MS makes this the method of
choice for the replacement of animal tests in the determination of lipophilic shellfish toxins
and their metabolites. Azaspiracid analysis using most MS analysers that can be
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incorporated in LC-ESI-MS has been described in numerous publications. [229] The
inherent advantages and limitations of these analysers make each of them complementary
valuable for a particular purpose.
The triple-quadupole (QqQ) mass analyser, providing single ion monitoring (SIM) mode
for the neutral loss and parent ion scaiming allow a selective detection of compounds in the
same chemical class, while the multiple reaction monitoring (MRM) mode is particularly
useful for sensitive quantitation of these compounds. [263; 264; 268]
Quadrupole ion-traps (QIT) mass analysers have been used for low mass resolution
sequential MS" experiments, which proved to be very useful for structural elucidation of
azaspiracids [230; 266] and the determination of AZAs using LC-MS . However, these
experiments are limited by a low mass-cut. Both QqQ MS and QIT MS have low mass
resolution and are not able to separate monoisotopic ions from putative isobaric
compounds.
Hybrid quadrupole-time-of-flight (QqTOF) mass analysers aided the structural elucidation
of azaspiracid by high mass resolution with accurate mass measurements of precursor and
product ions. [228; 270]
The most recently employed approach for analysis of azaspiracids using non-target high
resolution full-scan FTMS method in combination with target low mass resolution CID
MS/MS mode made use of both mass analysers in the hybrid linear ion trap-Orbitrap mass
spectrometer. [118]
Although the chromatographic step is very useful for the separation of isomeric pairs in
particular, the unavailability of a stationary phase capable of accommodating the chemical
diversity of all azaspiracid analogues, known and unexpected, influence the result of the
analysis. Moreover, the development of chromatographic methods is often time-consuming
due to the diversity of azaspiracids. The trend of employing of the ultra high performance
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liquid chromatography (U-HPLC) with gradient elution still results in analysis times up to
five min. in addition to considerably high volumes of solvents used as mobile phases.
Therefore, the direct introduction of shellfish extracts into the mass spectrometer,
overcoming the chromatographic step, seemed to be an attractive alternative for analysis of
azaspiracids in complex biological matrices.
The aim of this study was to investigate the feasibility of using the automated, robotic,
chip-based nanoelectrospray (nanoESI) device (NanoMate HD, Advion BioSciences) for
the rapid screening of azaspiracids in shellfish. The coupling of the nanoelectrospray
source to the LTQ Orbitrap mass spectrometer operated at a ultra high resolution setting,
enabled isobaric protonated azaspiracid ions to be distinguished, as well as the separation
of the ions from most isobaric ions present in the matrix. The data dependent higher
collisionaly induced dissociation (HCD) MS/MS scans generated product ion spectra for
azaspiracids precursor ions detected in full-scan FTMS. The abundant diagnostic ions in
these spectra allowed the identification of azaspiracid isomers and predictable
fragmentation processes.
The nanoESI source is insensitive to ion suppression effects, which is in contrast with a
normal electrospray ion source. [301; 302] It is assumed however, that samples to be
analysed using nanoESI are reasonably clean. Although the solid phase extraction (SPE)
clean-up has been shown to be valuable for reducing matrix interferences as well as
increasing the concentration levels of the analytes of interest, thus increasing the sensitivity
of their determination. However, the shellfish extracts in this study were not subjected to
any SPE clean-up procedures prior to analysis in order to prevent unexpected losses of
azaspiracid analogues with differing sorption.
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7.2 Experimental section

7.2.1 Materials
Azaspiracid standards were prepared by isolation from contaminated mussel (M eduUs)
tissues using multiple chromatographic separation procedures similar to those described
previously. [182; 271] All solvents including ethyl acetate, methanol and acetonitrile were
purchased from Fisher Scientific (Dublin, Ireland). Trilluoroacetic acid (TFA) and
ammonium acetate were purchased from Sigma-Aldrich (Dublin, Ireland).
Blue mussels {Mytilus edulis), naturally contaminated with azaspiracids, were obtained
from County Donegal, North-West Ireland. Mussels (M edulis) were dissected into three
tissue compartments, gills, hepatopancreas (HP) and the remaining tissues (RT). Each
tissue compartment (0.5-1.0 g) was homogenized (Ultra Turrax, IKA, Germany) with
methanol (4 mL) in a centrifuge tube (50 mL) for 1 min, followed by centrifugation at 704
g (3000 rpm) for 3 min. The supernatant was transferred to a volumetric tlask (10 mL), the
extraction procedure was repeated, combined with the first extract and made up to 10 mL
with methanol. An aliquot (1 mL) was evaporated using nitrogen at 20 °C (TurboVap,
Zymark, MA, USA). The remaining residue was extracted using ethyl acetate (2x2 mL)
and the combined extracts were evaporated using nitrogen. The residue was reconstituted
in acetonitrile containing 0.05% TFA and ImM ammonium acetate (200 pL) and used for
nanoESl-MS analysis.

7.2.2 Automated nanoESI - NanoMate
The automated nanoelectrospray system consisting of the NanoMate HD (Advion
BioSciences), a robotic liquid sampling arm with a sample plate and a pipette tip rack, and
disposable nanoelectrospray ionization (ESI) chip, operates as both an autosampler and
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nanoESI source (Figure 7.1). Automated sample analysis is achieved by loading a
disposable, conductive pipette tip on a moveable sampling probe, aspirating a sample via
syringe pump from a 96-well plate and sequentially delivering to a ESI chip, which is a
fully integrated monolithic device consisting of a 20 x 20 array of nozzles fabricated on a
silicon chip. Nanoelectrospray is triggered by applying head pressure and high voltage to a
sample in the conductive pipette tip (Figure 7.2). The system is capable of infusing
samples at stable, very low flow rates and is easily controlled by the ChipSoft software.
The sample carryover is eliminated by using each nanospray nozzle and pipette tip only
once.

Figure 7.1. A NanoMate device with a stage door open, showing the sampling probe, and the
sample and tip stage.

135

Silicon chip bearing a
20 X 20 array of 10 pm ID
nanospray nozzles

Nanospray nozzle

MS
Orifice

10 pL conductive p ipette tip

Figure 7.2. Sequential photographs on the top showing the ESI chip with the array of
microfabricated nanoelectrospray nozzles. The bottom part is showing schematic representation for
a cross section of a disposable pipette tip holding sample and pressing against the inlet side of the
ESI chip. Nanoelectrospray towards the mass spectrometer ion orifice is triggered by applying high
voltage to the sample in the pipette tip.

7.2.3 Automated nanoESI source coupled to the LTQ Orbitrap MS
The NanoMate replaced a manufacturer’s ion source by mounting to the hybrid LIT MSFT MS (LTQ Orbitrap XL, Thermo Scientific) with a customised mounting bracket
(Figure 7.3). The sample and tip stage alignment, and the position of the chip were carried
out according to manufacturer’s instructions. The nanoelectrospray parameters, including
the gas pressure and the voltage applied, were optimised by infusion of AZAl standard
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(0.3 |ig/mL) into LIT mass analyser and monitoring the ion at m/z = 842.5 ([M+H]^). In
order to maintain a stable nanoelectrospray, these parameters need to be optimised prior to
every analytical sequence and varied within 0.1 - 0.4 psi for the nitrogen gas pressure and
1.35 - 1.75 kV for the voltage applied for the pipette tip.

1
j
-------

Figure 7.3. Schematic of the nanoelectrospray device coupled to the LTQ Orbitrap MS.

7.2.4 Analysis of azaspiracids on LTQ Orbitrap MS
The Orbitrap MS was calibrated using a solution containing L-methionyl-arginoyolphenylalanylalanine acetate (MRFA), caffeine and perfluoroalkyl triazine Ultramark 1621,
according to the manufacturer’s instructions. For the determination of azaspiracids, the
method consisted of three scan events; a) fiill-scan FTMS (Orbitrap XL) acquired at a
100,000 FWHM resolution setting, b) FTMS MS/MS data-dependent scan, using HCD, to
generate product ion spectra for the precursor ions from full-scan and c) CID MS/MS, with
precursor and product ion pairs (Table 7.1), using the LIT MS. Full-scan FTMS were
acquired as profile data and data-dependent MS/MS spectra were acquired with relative
collis:on energy (RCE) of 46 %, using an isolation window of 2 Da in centroid mode. The
mass range was 100 - 900 m/z in the Orbitrap analyser. The lock mass option was
employed by recalibration of the mass scale using the m/z values of two selected ions,
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[M+Na]^ from TFA and [M2+^^Cu]^ from acetonitrile. The CID MS/MS data were
obtained at low-resolution, as centroid data, in the LIT MS. An optimised 35 % RCE was
used, with an isolation window of 2 Da, to produce abundant [M+H-H20]^ and [M+HH20-C02]^ ions (Table 7.1). Operation of the MS instrumentation was controlled using
Xcalibur software (Thermo Scientific).

Table 7.1. m/z ratio of the parent and major fragment ions of 14
azaspiracids.
Toxin

IM+H-H20r

fM+H-H20-A-ring/^

AZAl

842.5

824.5

672.4

AZA2

856.5

838.5

672.4

AZA3

828.5

810.5

658.4

AZA4

844.5

826.5

658.4

AZA5

844.5

826.5

674.4

AZA6

842.5

824.5

658.4

AZA7

858.5

840.5

672.4

AZA8

858.5

840.5

688.4

AZA9

858.5

840.5

658.4

AZAIO

858.5

840.5

674.4

AZAll

872.5

854.5

672.4

AZA12

872.5

854.5

688.4

[M+H-HiO-COit

fM+H-H20-A-ring-C02t

AZA17

872.5

810.5

658.4

AZA19

886.5

824.5

658.4
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7.3 Results and discussion
Nanoelectrospray chip technology offers stable static spray resulting in increased
sensitivity, high sample throughput, low sample consumption and no sample carryover.
[303] Samples were introduced into the LTQ Orbitrap MS using the NanoMate HD
mounted in front of the LIT. Sample volumes of 4 pL were infused for a duration of 3 min.
It was possible to return the remaining sample to the well but this option was not used in
order not to prolong the time of the analysis. An increased sample analysis time, not
limited by LC elution times, enabled maximum data acquisition for samples.

7.3.1 High resolution full-scan FTMS
Analyses of azaspiracids using nanoESI, compared to heated electrospray ion source (HESl), are more affected by interferences from matrix. Figure 7.4 demonstrates the presence
of highly abundant isobaric interferences in a mussel hepatopancreas extract. One of the
disadvantages of direct analysis is that the components present in a sample are not
separated by the chromatographic column and thus may affect the analytical result.
However, ultra-high-resolution, with accurate mass measurements using narrow mass
tolerance windows, help resolve and identify azaspiracids from background matrix ions.
Thus, coupling a nanoESI source to Orbitrap mass analyser, operating at very high mass
resolution setting, greatly increases the confidence in azaspiracid identification. The
advantage inherent in using this hybrid instrument configuration is the ability to perform
non-target analysis using full-scan FTMS in the Orbitrap MS and simultaneously use
targeted MRM analysis in the LIT MS.
Full-scan FTMS, acquired at a 100,000 FWHM resolution setting, consist of the ions
present in mussel extract in a range 230 - 1000 m/z (Figure 7.4.A). When zooming in on
the high resolution data (Figure 7.4.B), several azaspiracid analogues can be detected. The
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ppm errors from the theoretical m/z values were calculated for all observed AZAs. The
calculated errors were within 1.4 ppm, with the external calibration, even for the AZA
analogues of lower abundance. The inserts in the Figure 7.4.B show resolved AZAS and
AZA2 precursor ions, [M+H]\ from the interfering isobaric ions.
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Figure 7.4. A)NanoESI-full-scan FTMS of mussel hepatopancreas extract, acquired at 100,000
FWHM resolution setting. B) Range of AZAs m/z with calculated ppm errors from theoretical m/z.
Inserts show resolved m/z peaks for AZA3 and AZA2 precursor ions [M+H]^.
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7.3.2 High precision in determination of the mass accuracy
The accuracy of mass measurement in Orbitrap MS is based on the precise measurement of
frequency of oscillating ions alongside the inner electrode. Very high mass accuracy (subppm) can be achieved by employing an internal mass calibration (lock mass) with every
measurement. To determine the precision of the accurate m/z measurements, four mussel
tissue extracts, of similar azaspiracid composition, were analysed ten times. In Figure 7.5,
the peak intensity is plotted against calculated error (ppm) from the theoretical m/z value
on the logarithmic scale. It is obvious from this figure that ions of higher intensity yield
higher mass accuracy data with better precision. The precision of the accurate mass
measurements slowly deteriorates with decreasing intensity of the ions. However, the m/z
values were measured with good mass accuracy, all within 1.5 ppm error, even for ions of
a very low intensity, demonstrating the power of Orbitrap MS to deliver high quality MS
data.

♦ 842.50545
■856.5211
^ 828.4898
• 844.48472
* 886.49528
• 872.47963

ppm error

Figure 7.5. Accurate mass measurements error values correlated with ion intensity of toxins in
shellfish tissue extracts from 40 analytical runs. The precursor ions [M+H]^ were extracted from
full-scan spectra with ± 2mDa of tolerance window.
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7.3.3 What mass resolving power is needed?
To determine the minimal resolving power at which the full-scan FTMS data should be
acquired and to ensure the separation of all azaspiracid analogues from the interfering
isobaric ions, the full-scan spectra of a mussel tissue extract was acquired at different
resolution settings. From figure 7.6 it is apparent that at least a 60,000 FWHM resolution is
required to separate AZA3 [M+Fl]^ ions and its most abundant isotopic peaks from
interfering ions, which results in good mass accuracy obtained for precursor ions, [M+H] ^,
[M+H]^ + 1 and [M+Fl]^ + 2 of AZA3 extracted from full-scan FTMS. Accurate mass
values were < 0.44 ppm for these ions using a 60,000 and a 100,000 resolution setting.
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Figure 7.6. Precursor ion [M+H]^ of AZA3, together with three most abundant isotopes, extracted
from full-scan FTMS with ± 2mDa tolerance window. Importance of mass resolving power is
demonstrated by showing the resolution of the AZA3 ion from the isobaric interference, acquired at
different resolution settings; together with calculated ppm error from the theoretical m/z values.
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7.3.4 Spectral Accuracy of Molecular Ions
The ability of a mass spectrometer to precisely measure the isotopic distribution of an ion,
defined as spectral accuracy, is a very important aid to compound identification. In a
previous study, involving several natural substances, the spectral accuracy capability of the
LTQ Orbitrap MS was investigated. As a result of this study it was concluded, that the
difference in the observed profile isotope pattern from the theoretical calculated pattern,
was least at a 7,500 FWHM resolving power but exceeded 10 % for some compounds at a
100,000 FWHM resolution setting. The increased spectral error observed at a higher
resolving power for compounds with complex fine structure was explained by the
phenomenon of isotopic beat patterns as observed in Fourier transform ion cyclotron
resonance (FTICR) MS. [141]

15k

Figure 7.7. Spectra of AZA2 showing an isotope pattern profile at 15,000 FWHM resolving power,
overlapped with theoretically calculated isotope pattern (red bars). Good spectral accuracy is
demonstrated for the [M+H] and [M+H]^ +1 ion, however [M+H]^ +2 and [M+H]^ +3 ions are not
resolved from AZA7-AZA10 isomers, thus demonstrating an importance of resolving power.
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I'he combination of high mass accuracy determination, together with peak intensity
information, generated by the natural abundance of the various isotopes present in the
compound, is very useful for establishing the elemental composition of small molecules.
As demonstrated previously, the spectral accuracy deteriorates for some compounds,
depending on their structure, with increased mass resolving power. Azaspiracid analogues
have very similar structure and therefore the spectral accuracy for AZA2 only is shown
here. The full-scan FTMS of a mussel tissue extract, acquired at different resolution
settings (7,500 - 100,000 FWHM), showed that similar results were obtained for the 7,500
and 15,000 resolution settings. The Figure 7.7 shows the spectra of AZA2 with the isotope
pattern profile obtained at 15,000 FWHM resolving power. This spectrum is overlapped
with a theoretically calculated [304] isotope pattern (red bars). Good spectral accuracy is
demonstrated for the [M+H]^ and [M+H]^ +1 isotopic ion, but the [M+H]^ +2 isotopic ion
(m/z 858.52787) was not resolved from AZA7-AZA10 isomers {m/z 858.50037) at a
15,000 FWHM resolution setting and therefore could not be used to aid the determination
of the elemental composition. As demonstrated previously, at least 60,000 FWHM
resolving power is necessary to resolve isobaric compounds in full-scan FTMS spectra
generated for azaspiracids in mussel tissue extracts. Good spectral accuracy was achieved
for AZA2 at 60,000 FWHM resolution setting due to resolution of [M+H]^ +2 isotopic ion
(m/z 858.52787) from AZA7-AZA10 isomers (m/z 858.50037) as shown in Figure 7.8.A.
The mass accuracy determined for all ions was within 0.97 ppm error. A very small
spectral error (1%) was observed for the AZA2 isotopic distribution at 100,000 FWHM.
Moreover, the m/z values were determined with better accuracy (< 0.29 ppm). Thus, the
highest resolving power possible on the Orbitrap XL is important for the purpose of
azaspiracids identification in mussel tissue extracts.
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Figure 7.8. Spectra of AZ\2 showing an isotope pattern profile at A) 60,000 FWHM and B)
100,000 FWHM resolving power, overlapped with theoretically calculated isotope pattern (red
bars).
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7.3.5 HCD MS/MS data for structural confirmation
Higher collisionally induced dissociation (HCD) MS/MS spectra were generated for
azaspiracid ions detected in full-scan FTMS. Since the isomeric azaspiracid analogues
were not chromatographically separated, the MS/MS spectra contained product ions
formed by all azaspiracid isomers present in the sample. Figure 7.9 shows HCD MS/MS
spectrum for AZA4 and AZA5. Based on the intensities of the most abundant diagnostic
ions [M+H-H20-A-ring]^, with a value of 658.4 m/z for AZA4 and 674.4 m/z for AZA5, it
can be concluded that concentration level of AZA4 is approximately three times higher
than the concentration of AZA5. Data dependent scan enabled the acquisition of HCD
MS/MS spectra for a wide range of azaspiracid analogues, including AZA21 (Figure 7.9)
and AZA23 (Figure 7.10).

658.39495

Figure 7.9. HCD MS/MS spectrum generated for precursor ion of the m/z 844.5 value with RCE
46%, showing the distinguishing product ion spectra for AZA4 (blue) and AZA5 (red).
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Figure 7.9. HCD MS/MS spectrum generated for precursor ion of AZA21 with the m/z of 888.5
value, spectrum was acquired with the RCE 46%.

Figure 7.10. HCD MS/MS spectrum generated for precursor ion of AZA23 with the m/z of 902.5
value, spectrum was acquired with the RCE 46%.
148

7.3.6 Quantitation of azaspiracids using full-scan FTMS
The possibility of quantitation of azaspiracid using matrix matched calibration curve was
also investigated. However, the linearity of the calibration using AZAl standai’d spiked
into mussel extract, for matrix matching, was satisfactory only in a range 0.003 - 0.3
pg/mL. The poor linearity is probably due to matrix interferences but these do not seem to
affect the analysis of azaspiracids in shellfish extract when using LC-HESI-MS/MS [118],
as a consequence of partial chromatographic separation of interferences. Moreover, the
type of ion source can determine the quality of result as well. Despite this drawback, the
direct analysis proved to be a very suitable approach for the rapid screening of azaspiracids
in mussel tissue extracts, especially to eliminate negative samples.

2E+10

0.35

Figure 7.11. Calibration curves for AZAl standard, n=6, in full-scan FTMS mode.
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7.4 Conclusion
A fully automated chip-based nanoelectrospray (nanoESI) robotic system coupled to ultra
high mass resolution Orbitrap MS, was explored for its application for the direct analysis
of azaspiracids in shellfish extracts. The main advantages of this system is a high
throughput of samples, resulting in increased sensitivity, low sample consumption, no
sample carryover and short times. Despite of the inability to generate reliable quantitative
data due to ion suppression, the method has great potential for qualitative analysis and has
proved to be a very useful tool for the rapid screening of azaspiracids in shellfish extracts.
Such an approach would be valuable in the biotoxin monitoring laboratories for
eliminating the negative samples that constitute the majority of samples and for rapidly
determined whether or not shellfish is safe for consumptions.
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